# Official Journal C 230/2009

| | ISSN 1725-2423
  doi:10.3000/17252423.C_2009.230.eng |
| --- | --- |
| Official Journal
  of the European Union | C 230 |
| | |
| English edition | Information and Notices | Volume 5224 September 2009 |

ISSN 1725-2423

doi:10.3000/17252423.C_2009.230.eng

Official Journal

of the European Union

C 230

English edition

Information and Notices

Volume 5224 September 2009

---

| Notice No | Contents | page |
| --- | --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | Commission |
| 2009/C 230/01 | Authorisation for State aid pursuant to Articles 87 and 88 of the EC Treaty — Cases where the Commission raises no objections (
  1
  ) | 1 |

Notice No

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

2009/C 230/01

Authorisation for State aid pursuant to Articles 87 and 88 of the EC Treaty — Cases where the Commission raises no objections (
  1
  )

1

1

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | European Parliament |
| 2009/C 230/02 | Conference of Community and European Affairs Committees of Parliaments of the European Union (COSAC) — Contribution of the XLI COSAC — Prague, 10-12 May 2009 | 5 |
| | Commission |
| 2009/C 230/03 | Euro exchange rates | 9 |
| 2009/C 230/04 | Public holidays schedule 2011 for European Community institutions | 10 |
| | NOTICES FROM MEMBER STATES |
| 2009/C 230/05 | Binding tariff information | 11 |
| | NOTICES CONCERNING THE EUROPEAN ECONOMIC AREA |
| | Commission |
| 2009/C 230/06 | Authorisation of State aid pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part 1 of Protocol 3 to the Surveillance and Court Agreement | 16 |
| 2009/C 230/07 | Authorisation of State aid pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part 1 of Protocol 3 to the Surveillance and Court Agreement | 17 |
| | Standing Committee of the EFTA States |
| 2009/C 230/08 | Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008 | 18 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

European Parliament

2009/C 230/02

Conference of Community and European Affairs Committees of Parliaments of the European Union (COSAC) — Contribution of the XLI COSAC — Prague, 10-12 May 2009

5

Commission

2009/C 230/03

Euro exchange rates

9

2009/C 230/04

Public holidays schedule 2011 for European Community institutions

10

NOTICES FROM MEMBER STATES

2009/C 230/05

Binding tariff information

11

NOTICES CONCERNING THE EUROPEAN ECONOMIC AREA

Commission

2009/C 230/06

Authorisation of State aid pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part 1 of Protocol 3 to the Surveillance and Court Agreement

16

2009/C 230/07

Authorisation of State aid pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part 1 of Protocol 3 to the Surveillance and Court Agreement

17

Standing Committee of the EFTA States

2009/C 230/08

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008

18

| | V   Announcements |
| --- | --- |
| | OTHER ACTS |
| | Commission |
| 2009/C 230/09 | Notice for the attention of Ghuma Abd’rabbah concerning his inclusion in the list referred to in Articles 2, 3 and 7 of Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with Usama bin Laden, the Al-Qaida network and the Taliban | 29 |

V   Announcements

OTHER ACTS

Commission

2009/C 230/09

Notice for the attention of Ghuma Abd’rabbah concerning his inclusion in the list referred to in Articles 2, 3 and 7 of Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with Usama bin Laden, the Al-Qaida network and the Taliban

29

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

| 24.9.2009 | EN | Official Journal of the European Union | C 230/1 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/1

---

Authorisation for State aid pursuant to Articles 87 and 88 of the EC Treaty

Cases where the Commission raises no objections

(Text with EEA relevance)

2009/C 230/01

| Date of adoption of the decision | 29.4.2009 |
| --- | --- |
| Reference number of State Aid | N 636/08 |
| Member State | Lithuania |
| Region | — |
| Title (and/or name of the beneficiary) | Inoklaster LT and Inoklaster LT+ |
| Legal basis | Ūkio ministro įsakymo dėl priemonės „Inoklaster LT“ ir „Inoklaster LT+“ finansavimo sąlygų aprašo patvirtinimo projektas, 2008 m. liepos 23 d. Vyriausybės nutarimas Nr. 788 dėl 2007–2013 m. ekonomikos augimo veiksmų programos |
| Type of measure | Aid scheme |
| Objective | Research and development, innovation |
| Form of aid | Direct grant |
| Budget | Annual budget: LTL 45,86 million; overall budget: LTL 229,3 million |
| Intensity | 50 % |
| Duration (period) | Until 31.12.2013 |
| Economic sectors | All sectors |
| Name and address of the granting authority | Ūkio ministerija |
| Gedimino pr. 38/2 |
| LT-01104 Vilnius |
| LIETUVA |

Date of adoption of the decision

29.4.2009

Reference number of State Aid

N 636/08

Member State

Lithuania

Region

—

Title (and/or name of the beneficiary)

Inoklaster LT and Inoklaster LT+

Legal basis

Ūkio ministro įsakymo dėl priemonės „Inoklaster LT“ ir „Inoklaster LT+“ finansavimo sąlygų aprašo patvirtinimo projektas, 2008 m. liepos 23 d. Vyriausybės nutarimas Nr. 788 dėl 2007–2013 m. ekonomikos augimo veiksmų programos

Type of measure

Aid scheme

Objective

Research and development, innovation

Form of aid

Direct grant

Budget

Annual budget: LTL 45,86 million; overall budget: LTL 229,3 million

Intensity

50 %

Duration (period)

Until 31.12.2013

Economic sectors

All sectors

Name and address of the granting authority

Ūkio ministerija

Gedimino pr. 38/2

LT-01104 Vilnius

LIETUVA

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

| Date of adoption of the decision | 29.5.2009 |
| --- | --- |
| Reference number of State Aid | N 6/09 |
| Member State | Italy |
| Region | Piemonte |
| Title (and/or name of the beneficiary) | Incentivazione alla produzione di energia elettrica da fonte solare su discariche esaurite ed in fase di gestione post-operativa |
| Legal basis | Deliberazione Giunta Regionale n. 36-9369 del 4,9,08; Programma Operativo Regionale Regione Piemonte, FESR 2007-2013, Asse II, Attività II.1,1 |
| Type of measure | Aid scheme |
| Objective | Environmental protection |
| Form of aid | Interest subsidy, direct grant |
| Budget | Overall budget: EUR 10 million |
| Intensity | 80 % |
| Duration (period) | Until 31.12.2014 |
| Economic sectors | Electricity, gas and water supply |
| Name and address of the granting authority | Regione Piemonte |
| Piazza Castello 165 |
| 10122 Torino TO |
| ITALIA |

Date of adoption of the decision

29.5.2009

Reference number of State Aid

N 6/09

Member State

Italy

Region

Piemonte

Title (and/or name of the beneficiary)

Incentivazione alla produzione di energia elettrica da fonte solare su discariche esaurite ed in fase di gestione post-operativa

Legal basis

Deliberazione Giunta Regionale n. 36-9369 del 4,9,08; Programma Operativo Regionale Regione Piemonte, FESR 2007-2013, Asse II, Attività II.1,1

Type of measure

Aid scheme

Objective

Environmental protection

Form of aid

Interest subsidy, direct grant

Budget

Overall budget: EUR 10 million

Intensity

80 %

Duration (period)

Until 31.12.2014

Economic sectors

Electricity, gas and water supply

Name and address of the granting authority

Regione Piemonte

Piazza Castello 165

10122 Torino TO

ITALIA

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

| Date of adoption of the decision | 2.7.2009 |
| --- | --- |
| Reference number of State Aid | NN 8/09 |
| Member State | Germany |
| Region | — |
| Title (and/or name of the beneficiary) | Übertragung von Naturschutzgebieten |
| Legal basis | Foerderrichtlinien fuer Naturschutzgrossprojekte vom 28. Juni 1993 |
| Type of measure | Aid scheme |
| Objective | Environmental protection |
| Form of aid | Direct grant |
| Budget | Annual budget: EUR 14 million |
| Intensity | — |
| Duration (period) | — |
| Economic sectors | — |
| Name and address of the granting authority | Bundesregierung von Deutschland |
| Other information | — |

Date of adoption of the decision

2.7.2009

Reference number of State Aid

NN 8/09

Member State

Germany

Region

—

Title (and/or name of the beneficiary)

Übertragung von Naturschutzgebieten

Legal basis

Foerderrichtlinien fuer Naturschutzgrossprojekte vom 28. Juni 1993

Type of measure

Aid scheme

Objective

Environmental protection

Form of aid

Direct grant

Budget

Annual budget: EUR 14 million

Intensity

—

Duration (period)

—

Economic sectors

—

Name and address of the granting authority

Bundesregierung von Deutschland

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

| Date of adoption of the decision | 19.8.2009 |
| --- | --- |
| Reference number of State Aid | N 421/09 |
| Member State | United Kingdom |
| Region | Wales |
| Title (and/or name of the beneficiary) | Welsh Assembly Government Rescue and Restructuring Scheme aid for SMEs |
| Legal basis | Sections 1(2), (3) & (7) of the Welsh Development Agency Act 1975 (being competencies which were vested in the Welsh Ministers pursuant to schedule 11 of the Government of Wales Act 2006) and Sections 70 & 71 of the Government of Wales Act 2006 |
| Type of measure | Individual aid |
| Objective | Rescue of firms in difficulty, Restructuring of firms in difficulty |
| Form of aid | Provision of risk capital, debt write-off, soft loan |
| Budget | — |
| Intensity | 60 % |
| Duration (period) | 1.9.2009-31.12.2013 |
| Economic sectors | All sectors |
| Name and address of the granting authority | Welsh Assembly Government |
| Cathays Park |
| Cardiff |
| CF10 3NQ |
| UNITED KINGDOM |

Date of adoption of the decision

19.8.2009

Reference number of State Aid

N 421/09

Member State

United Kingdom

Region

Wales

Title (and/or name of the beneficiary)

Welsh Assembly Government Rescue and Restructuring Scheme aid for SMEs

Legal basis

Sections 1(2), (3) & (7) of the Welsh Development Agency Act 1975 (being competencies which were vested in the Welsh Ministers pursuant to schedule 11 of the Government of Wales Act 2006) and Sections 70 & 71 of the Government of Wales Act 2006

Type of measure

Individual aid

Objective

Rescue of firms in difficulty, Restructuring of firms in difficulty

Form of aid

Provision of risk capital, debt write-off, soft loan

Budget

—

Intensity

60 %

Duration (period)

1.9.2009-31.12.2013

Economic sectors

All sectors

Name and address of the granting authority

Welsh Assembly Government

Cathays Park

Cardiff

CF10 3NQ

UNITED KINGDOM

Other information

Intensity is 60 % for medium-sized companies and 75 % for small-sized companies

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

| Date of adoption of the decision | 14.8.2009 |
| --- | --- |
| Reference number of State Aid | N 458/09 |
| Member State | Germany |
| Region | Hessen |
| Title (and/or name of the beneficiary) | Änderung der Beihilferegelung zur Rettung und Umstrukturierung von KMU in Hessen — Vereinfachtes Verfahren |
| Legal basis | Richtlinien für die Übernahmen von Bürgschaften und Garantien durch das Land Hessen für die gewerbliche Wirtschaft — Teil C: Bürgschaften zur Rettung und Umstrukturierung von Unternehmen in Schwierigkeiten; |
| Type of measure | Aid scheme |
| Objective | Rescue of firms in difficulty, restructuring of firms in difficulty |
| Form of aid | Guarantee |
| Budget | Annual budget: EUR 120 million; overall budget: EUR 360 million |
| Intensity | — |
| Duration (period) | 1.7.2009-31.12.2011 |
| Economic sectors | All sectors |
| Name and address of the granting authority | Hessisches Ministerium der Finanzen |
| Friedrich-Ebert-Allee 8 |
| 65185 Wiesbaden |
| DEUTSCHLAND |

Date of adoption of the decision

14.8.2009

Reference number of State Aid

N 458/09

Member State

Germany

Region

Hessen

Title (and/or name of the beneficiary)

Änderung der Beihilferegelung zur Rettung und Umstrukturierung von KMU in Hessen — Vereinfachtes Verfahren

Legal basis

Richtlinien für die Übernahmen von Bürgschaften und Garantien durch das Land Hessen für die gewerbliche Wirtschaft — Teil C: Bürgschaften zur Rettung und Umstrukturierung von Unternehmen in Schwierigkeiten;

Type of measure

Aid scheme

Objective

Rescue of firms in difficulty, restructuring of firms in difficulty

Form of aid

Guarantee

Budget

Annual budget: EUR 120 million; overall budget: EUR 360 million

Intensity

—

Duration (period)

1.7.2009-31.12.2011

Economic sectors

All sectors

Name and address of the granting authority

Hessisches Ministerium der Finanzen

Friedrich-Ebert-Allee 8

65185 Wiesbaden

DEUTSCHLAND

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

European Parliament

| 24.9.2009 | EN | Official Journal of the European Union | C 230/5 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/5

---

Conference of Community and European Affairs Committees of Parliaments of the European Union (COSAC)

Contribution of the XLI COSAC

Prague, 10-12 May 2009

2009/C 230/02

1.   Current economic and financial situation

| 1.1. | COSAC affirms that the EU faces one of the greatest challenges in its history posed by the current economic, financial and social crisis. The economic downturn affects and concerns EU citizens. Therefore targeted and coordinated action is required from supranational and intergovernmental bodies. |
| --- | --- |

1.1.

COSAC affirms that the EU faces one of the greatest challenges in its history posed by the current economic, financial and social crisis. The economic downturn affects and concerns EU citizens. Therefore targeted and coordinated action is required from supranational and intergovernmental bodies.

| 1.2. | COSAC notes that the crisis has hit each Member State differently. COSAC therefore deems it important to have regard to each Member State's specific situation and varying needs and to take action accordingly. COSAC welcomes the action undertaken in solidarity with the worst affected Member States. |
| --- | --- |

1.2.

COSAC notes that the crisis has hit each Member State differently. COSAC therefore deems it important to have regard to each Member State's specific situation and varying needs and to take action accordingly. COSAC welcomes the action undertaken in solidarity with the worst affected Member States.

| 1.3. | COSAC welcomes the Conclusions of the European Council of 19 and 20 March 2009 and the Council's effort to tackle the economic crisis through the fiscal stimulus package which contains measures to encourage and strengthen the European economy both in the short and long terms. COSAC underlines the progress already achieved since December 2008 through the implementation of the European Economic Recovery Plan (notably promoting investments in the field of the Trans-European Networks and boosting the SME financing possibilities) and through the reform of the European Globalisation Adjustment Fund that will reinforce its efficiency. COSAC in this respect recalls the important role of the common currency for those countries which are part of it and of maintaining sustainable public finances in the long term. |
| --- | --- |

1.3.

COSAC welcomes the Conclusions of the European Council of 19 and 20 March 2009 and the Council's effort to tackle the economic crisis through the fiscal stimulus package which contains measures to encourage and strengthen the European economy both in the short and long terms. COSAC underlines the progress already achieved since December 2008 through the implementation of the European Economic Recovery Plan (notably promoting investments in the field of the Trans-European Networks and boosting the SME financing possibilities) and through the reform of the European Globalisation Adjustment Fund that will reinforce its efficiency. COSAC in this respect recalls the important role of the common currency for those countries which are part of it and of maintaining sustainable public finances in the long term.

| 1.4. | COSAC is aware of the rapid increase in unemployment as a cause of great concern. The Member States, in particular, have the responsibility to prevent and limit job losses and negative social impacts. |
| --- | --- |

1.4.

COSAC is aware of the rapid increase in unemployment as a cause of great concern. The Member States, in particular, have the responsibility to prevent and limit job losses and negative social impacts.

| 1.5. | COSAC supports the European Council’s intention to improve regulation and supervision of financial institutions. Restoring the confidence of citizens and investors in the financial markets and the proper functioning of these markets are of primary importance for a return to economic stability. |
| --- | --- |

1.5.

COSAC supports the European Council’s intention to improve regulation and supervision of financial institutions. Restoring the confidence of citizens and investors in the financial markets and the proper functioning of these markets are of primary importance for a return to economic stability.

| 1.6. | COSAC warns against all forms of economic protectionism. COSAC also recalls that openness of world markets and a renewed effort to conclude the Doha round remain key to successfully overcoming the global crisis. |
| --- | --- |

1.6.

COSAC warns against all forms of economic protectionism. COSAC also recalls that openness of world markets and a renewed effort to conclude the Doha round remain key to successfully overcoming the global crisis.

| 1.7. | COSAC supports the new EU rules on the management of EU funds and encourages the Commission and the European Parliament further to analyse and adapt these rules in order to improve the managing of the funds, thus helping to speed up their allocation. |
| --- | --- |

1.7.

COSAC supports the new EU rules on the management of EU funds and encourages the Commission and the European Parliament further to analyse and adapt these rules in order to improve the managing of the funds, thus helping to speed up their allocation.

| 1.8. | COSAC reiterates in this context that the economic slowdown must not lead the European Union to lower its ambitions in terms of sustainable development and the climate strategy as adopted by the European Council. |
| --- | --- |

1.8.

COSAC reiterates in this context that the economic slowdown must not lead the European Union to lower its ambitions in terms of sustainable development and the climate strategy as adopted by the European Council.

2.   The role of EU parliaments in the promotion of human rights and democracy in the world

| 2.1. | COSAC notes that protection of human rights and promotion of democracy in the world are among the most important issues for EU parliaments. The 20th anniversary of the fall of the Iron Curtain, and liberation from communism, highlights the significance of democratic countries insisting on respect for human rights. COSAC thanks the former Czech President Václav Havel for his valuable contribution to the promotion of human rights and democracy in the world. |
| --- | --- |

2.1.

COSAC notes that protection of human rights and promotion of democracy in the world are among the most important issues for EU parliaments. The 20th anniversary of the fall of the Iron Curtain, and liberation from communism, highlights the significance of democratic countries insisting on respect for human rights. COSAC thanks the former Czech President Václav Havel for his valuable contribution to the promotion of human rights and democracy in the world.

| 2.2. | COSAC shares the European Parliament’s view expressed in its recent resolution on European conscience and totalitarianism that the documentation of Europe’s troubled past must be supported, as reconciliation would be difficult without disclosure and assessment of the crimes committed by the totalitarian regimes. COSAC notes the European Parliament’s appeal for the establishment of a platform of European memory and conscience that would connect present national activities related to examination and remembrance of totalitarian regimes. |
| --- | --- |

2.2.

COSAC shares the European Parliament’s view expressed in its recent resolution on European conscience and totalitarianism that the documentation of Europe’s troubled past must be supported, as reconciliation would be difficult without disclosure and assessment of the crimes committed by the totalitarian regimes. COSAC notes the European Parliament’s appeal for the establishment of a platform of European memory and conscience that would connect present national activities related to examination and remembrance of totalitarian regimes.

| 2.3. | COSAC reiterates that human trafficking comprises serious violations of fundamental human rights and human dignity which can only be tackled properly through a joint effort of EU Member States. |
| --- | --- |

2.3.

COSAC reiterates that human trafficking comprises serious violations of fundamental human rights and human dignity which can only be tackled properly through a joint effort of EU Member States.

| 2.4. | COSAC also reiterates the importance of EU parliaments cooperating with bodies such as the Council of Europe in promoting human rights and democracy in the world. It also stresses that, faced with opposition from some countries in international institutions, the EU should carry on supporting firmly the universal nature of human rights, as has been proclaimed by the international community in the Universal Declaration of Human Rights. |
| --- | --- |

2.4.

COSAC also reiterates the importance of EU parliaments cooperating with bodies such as the Council of Europe in promoting human rights and democracy in the world. It also stresses that, faced with opposition from some countries in international institutions, the EU should carry on supporting firmly the universal nature of human rights, as has been proclaimed by the international community in the Universal Declaration of Human Rights.

| 2.5. | COSAC welcomes the insertion of ‘human rights and democracy suspension clauses’ in treaties the EC agrees with third countries. These clauses are an effective tool allowing for better parliamentary control of human rights and protection of democracy. |
| --- | --- |

2.5.

COSAC welcomes the insertion of ‘human rights and democracy suspension clauses’ in treaties the EC agrees with third countries. These clauses are an effective tool allowing for better parliamentary control of human rights and protection of democracy.

| 2.6. | In the light of the present human rights situation in certain third countries, COSAC stresses the importance of further substantial promotion of human rights in the EU’s relations with these countries. COSAC regrets the fact that there are countries where human rights protection has deteriorated recently despite the joint effort of the EU Member States and the attention EU pays to the rule of law. |
| --- | --- |

2.6.

In the light of the present human rights situation in certain third countries, COSAC stresses the importance of further substantial promotion of human rights in the EU’s relations with these countries. COSAC regrets the fact that there are countries where human rights protection has deteriorated recently despite the joint effort of the EU Member States and the attention EU pays to the rule of law.

| 2.7. | COSAC notes with satisfaction that the European Union is moving towards a consensus as regards its policies on supporting democracy. In this context it encourages the European Commission to make additional progress with a view to the implementation of the European Instrument for Democracy and Human Rights (EIDHR) which entered into force on 1 January 2007. It urges the creation of synergies with the existing activities of the Council of Europe and making full use of the instruments of the Council of Europe. COSAC supports the accession of the European Union to the European Convention on Human Rights, thus strengthening by all means the European Court of Human Rights. |
| --- | --- |

2.7.

COSAC notes with satisfaction that the European Union is moving towards a consensus as regards its policies on supporting democracy. In this context it encourages the European Commission to make additional progress with a view to the implementation of the European Instrument for Democracy and Human Rights (EIDHR) which entered into force on 1 January 2007. It urges the creation of synergies with the existing activities of the Council of Europe and making full use of the instruments of the Council of Europe. COSAC supports the accession of the European Union to the European Convention on Human Rights, thus strengthening by all means the European Court of Human Rights.

3.   Parliamentary oversight of Europol and evaluation of Eurojust

| 3.1. | COSAC welcomes the will of national parliaments and the European Parliament to scrutinise Europol’s and to evaluate Eurojust’s activities as set out in the discussions at the Paris and Prague meetings and in the 11th Biannual Report. |
| --- | --- |

3.1.

COSAC welcomes the will of national parliaments and the European Parliament to scrutinise Europol’s and to evaluate Eurojust’s activities as set out in the discussions at the Paris and Prague meetings and in the 11th Biannual Report.

| 3.2. | COSAC recalls that the conclusions of the Speakers’ Conference in Paris on 27 and 28 February 2009 stressed the importance of the role of national parliaments in the assessment and the monitoring of the construction of a European area of freedom, security and justice. COSAC is aware that the legal basis for joint parliamentary oversight of Europol and Eurojust would be created by the Treaty of Lisbon. COSAC encourages parliaments to continue all necessary preparations so that the national parliaments and the European Parliament are ready for their new role if the Treaty comes into force. |
| --- | --- |

3.2.

COSAC recalls that the conclusions of the Speakers’ Conference in Paris on 27 and 28 February 2009 stressed the importance of the role of national parliaments in the assessment and the monitoring of the construction of a European area of freedom, security and justice. COSAC is aware that the legal basis for joint parliamentary oversight of Europol and Eurojust would be created by the Treaty of Lisbon. COSAC encourages parliaments to continue all necessary preparations so that the national parliaments and the European Parliament are ready for their new role if the Treaty comes into force.

| 3.3. | COSAC considers that the mechanisms for parliamentary oversight are crucial as Europol and Eurojust's powers are increasing and thus the there is a constantly reiterated need for proper democratic oversight of these bodies. Such oversight can only be carried out by national parliaments and the European Parliament together as they possess a mandate from Europe's citizens. |
| --- | --- |

3.3.

COSAC considers that the mechanisms for parliamentary oversight are crucial as Europol and Eurojust's powers are increasing and thus the there is a constantly reiterated need for proper democratic oversight of these bodies. Such oversight can only be carried out by national parliaments and the European Parliament together as they possess a mandate from Europe's citizens.

| 3.4. | COSAC discussed oversight mechanisms and as a result has identified different possible approaches. COSAC has agreed to use the existing interparliamentary forms of cooperation for this purpose. |
| --- | --- |

3.4.

COSAC discussed oversight mechanisms and as a result has identified different possible approaches. COSAC has agreed to use the existing interparliamentary forms of cooperation for this purpose.

| 3.5. | COSAC reiterates the request of the XL COSAC in Paris, that the European Commission should seek the views of the national parliaments and the European Parliament via a consultation document before finalising proposals for dealing with the parliamentary oversight of Europol and Eurojust. Furthermore, after the Commission issues these proposals, the Council and the European Parliament are requested to enter into dialogue with national parliaments giving them reasonable time to express their views, in the course of which they may in turn consult each other. Any legislative proposals must be guided by the principle that Europol's and Eurojust’s operational activities are independent of political interference. |
| --- | --- |

3.5.

COSAC reiterates the request of the XL COSAC in Paris, that the European Commission should seek the views of the national parliaments and the European Parliament via a consultation document before finalising proposals for dealing with the parliamentary oversight of Europol and Eurojust. Furthermore, after the Commission issues these proposals, the Council and the European Parliament are requested to enter into dialogue with national parliaments giving them reasonable time to express their views, in the course of which they may in turn consult each other. Any legislative proposals must be guided by the principle that Europol's and Eurojust’s operational activities are independent of political interference.

4.   Eastern dimension of the European Neighbourhood Policy

| 4.1. | COSAC reiterates its long-term support for strengthening the European Neighbourhood Policy. It welcomed the recent boost to the policy’s southern dimension by establishing the Union for the Mediterranean. |
| --- | --- |

4.1.

COSAC reiterates its long-term support for strengthening the European Neighbourhood Policy. It welcomed the recent boost to the policy’s southern dimension by establishing the Union for the Mediterranean.

| 4.2. | COSAC also stresses the importance of well-established relations with its eastern neighbours. COSAC considers the Eastern Partnership to be a useful tool for maintaining and fostering relations with the third countries involved and therefore supports the initiative and is keen to encourage its further development. |
| --- | --- |

4.2.

COSAC also stresses the importance of well-established relations with its eastern neighbours. COSAC considers the Eastern Partnership to be a useful tool for maintaining and fostering relations with the third countries involved and therefore supports the initiative and is keen to encourage its further development.

| 4.3. | COSAC welcomes the results of the Eastern Partnership founding Summit held in Prague on 7 May 2009 as expressed in the joint Declaration. COSAC especially welcomes the establishment of the partnership on commitments to democracy, the rule of law and respect for human rights and the focus on enhanced multilateral cooperation that should not only foster relations between the EU and the eastern partners, but also strengthen the relations between the eastern partnership countries themselves. |
| --- | --- |

4.3.

COSAC welcomes the results of the Eastern Partnership founding Summit held in Prague on 7 May 2009 as expressed in the joint Declaration. COSAC especially welcomes the establishment of the partnership on commitments to democracy, the rule of law and respect for human rights and the focus on enhanced multilateral cooperation that should not only foster relations between the EU and the eastern partners, but also strengthen the relations between the eastern partnership countries themselves.

| 4.4. | COSAC notes with satisfaction that the joint declaration stipulates that European Union financial support will be provided serving the goals of the Eastern Partnership and taking into consideration progress made by individual Eastern Partners. |
| --- | --- |

4.4.

COSAC notes with satisfaction that the joint declaration stipulates that European Union financial support will be provided serving the goals of the Eastern Partnership and taking into consideration progress made by individual Eastern Partners.

| 4.5. | COSAC encourages the next Council presidencies to continue developing good, effective and conditional relations with the partner countries through the Eastern Partnership framework. COSAC underlines the importance of stability and security in the eastern dimension. Peace and security and the rule of law with respect for territorial integrity remain fundamental for strengthening democracy and respect for human rights. In this context, increasing parliamentary exchanges and meetings can play a very positive role in ensuring a stable, secure and prosperous neighbourhood. |
| --- | --- |

4.5.

COSAC encourages the next Council presidencies to continue developing good, effective and conditional relations with the partner countries through the Eastern Partnership framework. COSAC underlines the importance of stability and security in the eastern dimension. Peace and security and the rule of law with respect for territorial integrity remain fundamental for strengthening democracy and respect for human rights. In this context, increasing parliamentary exchanges and meetings can play a very positive role in ensuring a stable, secure and prosperous neighbourhood.

| 4.6. | COSAC supports the ongoing negotiations with Russia for a new partnership and cooperation agreement. With regard to its previous debates COSAC reaffirms its stance that cooperation in the framework of the new agreement should also concentrate on issues of democracy and human rights. |
| --- | --- |

4.6.

COSAC supports the ongoing negotiations with Russia for a new partnership and cooperation agreement. With regard to its previous debates COSAC reaffirms its stance that cooperation in the framework of the new agreement should also concentrate on issues of democracy and human rights.

| 4.7. | COSAC notes that the EU must ensure real and effective complementarities between the Eastern Partnership and other cooperation mechanisms (e.g. Black Sea Synergy). |
| --- | --- |

4.7.

COSAC notes that the EU must ensure real and effective complementarities between the Eastern Partnership and other cooperation mechanisms (e.g. Black Sea Synergy).

5.   Annual Policy Strategy 2010

| 5.1. | COSAC reiterates its intention to discuss the Annual Policy Strategy of the European Commission on a regular basis. The Annual Policy Strategy represents a welcome initial source of information for effective parliamentary scrutiny. It facilitates the EU parliaments’ early involvement in the EU's decision-making process. |
| --- | --- |

5.1.

COSAC reiterates its intention to discuss the Annual Policy Strategy of the European Commission on a regular basis. The Annual Policy Strategy represents a welcome initial source of information for effective parliamentary scrutiny. It facilitates the EU parliaments’ early involvement in the EU's decision-making process.

| 5.2. | COSAC expects the next Commission to continue the current political dialogue with national parliaments: the so-called Barroso initiative. This initiative has found good resonance in the national parliaments. COSAC hopes that the next Commission will build on the existing submissions from national parliaments and take them into account in the process of further policy formulation. |
| --- | --- |

5.2.

COSAC expects the next Commission to continue the current political dialogue with national parliaments: the so-called Barroso initiative. This initiative has found good resonance in the national parliaments. COSAC hopes that the next Commission will build on the existing submissions from national parliaments and take them into account in the process of further policy formulation.

---

Commission

| 24.9.2009 | EN | Official Journal of the European Union | C 230/9 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/9

---

Euro exchange rates (1)

23 September 2009

2009/C 230/03

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,4783 |
| JPY | Japanese yen | 134,96 |
| DKK | Danish krone | 7,4418 |
| GBP | Pound sterling | 0,89940 |
| SEK | Swedish krona | 10,0778 |
| CHF | Swiss franc | 1,5123 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,5640 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,244 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 271,27 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7063 |
| PLN | Polish zloty | 4,1925 |
| RON | Romanian leu | 4,2283 |
| TRY | Turkish lira | 2,1918 |
| AUD | Australian dollar | 1,6906 |
| CAD | Canadian dollar | 1,5794 |
| HKD | Hong Kong dollar | 11,4578 |
| NZD | New Zealand dollar | 2,0368 |
| SGD | Singapore dollar | 2,0879 |
| KRW | South Korean won | 1 765,03 |
| ZAR | South African rand | 10,9509 |
| CNY | Chinese yuan renminbi | 10,0910 |
| HRK | Croatian kuna | 7,2682 |
| IDR | Indonesian rupiah | 14 341,48 |
| MYR | Malaysian ringgit | 5,1230 |
| PHP | Philippine peso | 70,131 |
| RUB | Russian rouble | 44,4070 |
| THB | Thai baht | 49,604 |
| BRL | Brazilian real | 2,6505 |
| MXN | Mexican peso | 19,7856 |
| INR | Indian rupee | 70,9660 |

Currency

Exchange rate

USD

US dollar

1,4783

JPY

Japanese yen

134,96

DKK

Danish krone

7,4418

GBP

Pound sterling

0,89940

SEK

Swedish krona

10,0778

CHF

Swiss franc

1,5123

ISK

Iceland króna

NOK

Norwegian krone

8,5640

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,244

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

271,27

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7063

PLN

Polish zloty

4,1925

RON

Romanian leu

4,2283

TRY

Turkish lira

2,1918

AUD

Australian dollar

1,6906

CAD

Canadian dollar

1,5794

HKD

Hong Kong dollar

11,4578

NZD

New Zealand dollar

2,0368

SGD

Singapore dollar

2,0879

KRW

South Korean won

1 765,03

ZAR

South African rand

10,9509

CNY

Chinese yuan renminbi

10,0910

HRK

Croatian kuna

7,2682

IDR

Indonesian rupiah

14 341,48

MYR

Malaysian ringgit

5,1230

PHP

Philippine peso

70,131

RUB

Russian rouble

44,4070

THB

Thai baht

49,604

BRL

Brazilian real

2,6505

MXN

Mexican peso

19,7856

INR

Indian rupee

70,9660

---

(1)  Source: reference exchange rate published by the ECB.

---

| 24.9.2009 | EN | Official Journal of the European Union | C 230/10 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/10

---

PUBLIC HOLIDAYS SCHEDULE 2011 FOR EUROPEAN COMMUNITY INSTITUTIONS

2009/C 230/04

The public holidays in 2011 for the staff of the European Community Institutions in Brussels and Luxembourg shall be as follows:

| 21 April | Maundy Thursday |
| --- | --- |
| 22 April | Good Friday |
| 25 April | Easter Monday |
| 9 May | Monday, anniversary of the declaration made by President Robert Schuman in 1950 |
| 2 June | Thursday, Ascension Day |
| 3 June | Friday, the day following Ascension Day |
| 13 June | Whit Monday |
| 21 July | Thursday, Belgian national holiday |
| 15 August | Monday, Assumption Day |
| 1 November | Tuesday, All Saints’ Day |
| 2 November | Wednesday, All Souls’ Day |
| 23 December to | Friday | (6 end-of-year days) |
| 30 December | Friday |
| TOTAL: 17 days |

21 April

Maundy Thursday

22 April

Good Friday

25 April

Easter Monday

9 May

Monday, anniversary of the declaration made by President Robert Schuman in 1950

2 June

Thursday, Ascension Day

3 June

Friday, the day following Ascension Day

13 June

Whit Monday

21 July

Thursday, Belgian national holiday

15 August

Monday, Assumption Day

1 November

Tuesday, All Saints’ Day

2 November

Wednesday, All Souls’ Day

23 December to

Friday

(6 end-of-year days)

30 December

Friday

TOTAL: 17 days

LUXEMBOURG: the above mentioned dates also apply to Luxembourg, except that Thursday 21 July is replaced by Thursday 23 June, the Luxembourg national holiday.

Work will resume as normal on Tuesday 3 January 2012.

Without prejudice to the public holiday schedule for 2012, Monday 2 January 2012 shall be deemed a public holiday under that year’s entitlements.

The Commission reserves the right to modify these provisions should the needs of the service so require.

---

NOTICES FROM MEMBER STATES

| 24.9.2009 | EN | Official Journal of the European Union | C 230/11 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/11

---

BINDING TARIFF INFORMATION

2009/C 230/05

List of customs authorities designated by Member States for the purposes of receiving applications for, or issuing binding tariff information, adopted in accordance with Article 6(5) of Commission Regulation (EEC) No 2454/93 (1), as last amended by Regulation (EC) No 214/2007 (2).

| Member State | Customs Authority |
| --- | --- |
| AUSTRIA | Customs authorities designated for the purpose of receiving applications and issuing binding tariff information |
| Zentralstelle für Verbindliche Zolltarifauskünfte |
| Vordere Zollamtsstraße 5 |
| 1030 Wien |
| ÖSTERREICH |

Member State

Customs Authority

AUSTRIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

Zentralstelle für Verbindliche Zolltarifauskünfte

Vordere Zollamtsstraße 5

1030 Wien

ÖSTERREICH

BELGIUM

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Centrale administratie der douane en accijnzen |
| --- |
| Dienst Nomenclatuur (Tarief), Landbouw en Waarde |
| Cel BTI |
| North Galaxy — Gebouw A — 8ste verdieping |
| Koning Albert II laan 33 |
| 1030 Brussel |
| BELGIË |

Centrale administratie der douane en accijnzen

Dienst Nomenclatuur (Tarief), Landbouw en Waarde

Cel BTI

North Galaxy — Gebouw A — 8ste verdieping

Koning Albert II laan 33

1030 Brussel

BELGIË

| Administration centrale des douanes et accises |
| --- |
| Service Nomenclature (Tarif), Agriculture et Valeur |
| Cellule RTC |
| North Galaxy Bâtiment A — 8ième étage |
| 33 Avenue Albert II |
| 1030 Bruxelles |
| BELGIQUE |

Administration centrale des douanes et accises

Service Nomenclature (Tarif), Agriculture et Valeur

Cellule RTC

North Galaxy Bâtiment A — 8ième étage

33 Avenue Albert II

1030 Bruxelles

BELGIQUE

BULGARIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Агенция „Митници“ |
| --- |
| Централно митническо управление |
| ул. „Г. С. Раковски“ No 47 |
| 1202 София/Sofia |
| БЪПГАРИЯ/BULGARIA |

Агенция „Митници“

Централно митническо управление

ул. „Г. С. Раковски“ No 47

1202 София/Sofia

БЪПГАРИЯ/BULGARIA

CYPRUS

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Τμήμα Τελωνείων |
| --- |
| Υπουργείο Οικονομικών |
| Γωνία Μ. Καραολή και Γρ. Αυξεντίου |
| 1096 Λευκωσία |
| Ταχ. Διεύθυνση: Αρχιτελωνείο |
| 1440 Λευκωσία/Nicosia |
| ΚΥΠΡΟΣ/CYPRUS |

Τμήμα Τελωνείων

Υπουργείο Οικονομικών

Γωνία Μ. Καραολή και Γρ. Αυξεντίου

1096 Λευκωσία

Ταχ. Διεύθυνση: Αρχιτελωνείο

1440 Λευκωσία/Nicosia

ΚΥΠΡΟΣ/CYPRUS

CZECH REPUBLIC

Customs authorities designated for the purpose of issuing binding tariff information

| Celní ředitelství Praha |
| --- |
| Washingtonova 7 |
| 113 54 Praha 1 |
| ČESKÁ REPUBLIKA |

Celní ředitelství Praha

Washingtonova 7

113 54 Praha 1

ČESKÁ REPUBLIKA

Customs authorities designated for the purpose of receiving applications for binding tariff information

| Celní ředitelství Praha |
| --- |
| Oddělení závazných informací |
| Washingtonova 7 |
| 113 54 Praha 1 |
| ČESKÁ REPUBLIKA |

Celní ředitelství Praha

Oddělení závazných informací

Washingtonova 7

113 54 Praha 1

ČESKÁ REPUBLIKA

DENMARK

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Skat Århus |
| --- |
| (Told — Tariferingscentret) |
| Lyseng Allé 1 |
| 8270 Højbjerg |
| DANMARK |

Skat Århus

(Told — Tariferingscentret)

Lyseng Allé 1

8270 Højbjerg

DANMARK

(applicants with business address in Nordjylland, Midtjylland and Sydjylland-Fyn)

| Skat København |
| --- |
| Told — Tariferingscentret |
| Sluseholmen 8 B |
| 2450 København SV |
| DANMARK |

Skat København

Told — Tariferingscentret

Sluseholmen 8 B

2450 København SV

DANMARK

(other applicants)

ESTONIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Maksu- ja Tolliamet |
| --- |
| Narva mnt 9j |
| 15176 Tallinn |
| EESTI/ESTONIA |

Maksu- ja Tolliamet

Narva mnt 9j

15176 Tallinn

EESTI/ESTONIA

FINLAND

Customs authorities designated for the purpose of issuing binding tariff information

| Tullihallitus – Nimikkeistö- ja tullietuusyksikkö |
| --- |
| Erottajankatu 2 |
| PL 512 |
| FI-00101 Helsinki |
| SUOMI/FINLAND |

Tullihallitus – Nimikkeistö- ja tullietuusyksikkö

Erottajankatu 2

PL 512

FI-00101 Helsinki

SUOMI/FINLAND

| Tullstyrelsen – Enheten för nomenklatur och tullförmåner |
| --- |
| Skillnadsgatan 2 |
| PB 512 |
| FI-00101 Helsingfors |
| SUOMI/FINLAND |

Tullstyrelsen – Enheten för nomenklatur och tullförmåner

Skillnadsgatan 2

PB 512

FI-00101 Helsingfors

SUOMI/FINLAND

Customs authorities designated for the purpose of receiving applications for binding tariff information

Board of Customs and all customs offices

FRANCE

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Direction générale des Douanes et Droits indirects, bureau E4 |
| --- |
| 11 rue des deux Communes |
| 93558 Montreuil Cédex |
| FRANCE |

Direction générale des Douanes et Droits indirects, bureau E4

11 rue des deux Communes

93558 Montreuil Cédex

FRANCE

GERMANY

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Hauptzollamt Hannover |
| --- |
| Waterloostraße 5 |
| 30169 Hannover |
| DEUTSCHLAND |

Hauptzollamt Hannover

Waterloostraße 5

30169 Hannover

DEUTSCHLAND

GREECE

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Υπουργειο Οικονομιασ & Οικονομικων |
| --- |
| Γενική Γραμματεία Φορολογικών & Τελωνειακών Θεμάτων |
| Γενική Διεύθυνση Τελωνείων & Ειδικών Φόρων Κατανάλωσης |
| Διεύθυνση Δασμολογική (Δ.17) |
| Τμήμα Α' (Δασμολογικό) |
| Ταχ.Δ/νση: Λεωφ. Αμαλίας 40 — T.K. |
| 105 58 Αθήνα/Athens |
| ΕΛΛΑΔΑ/GREECE |

Υπουργειο Οικονομιασ & Οικονομικων

Γενική Γραμματεία Φορολογικών & Τελωνειακών Θεμάτων

Γενική Διεύθυνση Τελωνείων & Ειδικών Φόρων Κατανάλωσης

Διεύθυνση Δασμολογική (Δ.17)

Τμήμα Α' (Δασμολογικό)

Ταχ.Δ/νση: Λεωφ. Αμαλίας 40 — T.K.

105 58 Αθήνα/Athens

ΕΛΛΑΔΑ/GREECE

HUNGARY

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Vám- és Pénzügyőrség |
| --- |
| Vegyvizsgáló Intézete |
| Budapest |
| Hősök fasora 20–24. |
| 1163 |
| MAGYARORSZÁG/HUNGARY |

Vám- és Pénzügyőrség

Vegyvizsgáló Intézete

Budapest

Hősök fasora 20–24.

1163

MAGYARORSZÁG/HUNGARY

IRELAND

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Office of the Revenue Commissioners |
| --- |
| Classification Unit |
| Customs Procedures Branch |
| Government Offices |
| Nenagh |
| Co. Tipperary |
| ÉIRE |

Office of the Revenue Commissioners

Classification Unit

Customs Procedures Branch

Government Offices

Nenagh

Co. Tipperary

ÉIRE

ITALY

Customs authorities designated for the purpose of issuing binding tariff information

| Agenzia delle Dogane |
| --- |
| Ufficio Applicazione Tributi |
| Via Mario Carucci 71 |
| 00143 Roma RM |
| ITALIA |

Agenzia delle Dogane

Ufficio Applicazione Tributi

Via Mario Carucci 71

00143 Roma RM

ITALIA

Customs authorities designated for the purpose of receiving applications for binding tariff information

All customs offices

LATVIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Valsts ieņēmumu dienests |
| --- |
| Galvenā muitas pārvalde |
| 11. novembra krastmala 17 |
| Rīga, LV-1841 |
| LATVIJA |

Valsts ieņēmumu dienests

Galvenā muitas pārvalde

11. novembra krastmala 17

Rīga, LV-1841

LATVIJA

LITHUANIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Muitinės departamentas prie Lietuvos Respublikos finansų ministerijos |
| --- |
| A. Jakšto g. 1/25 |
| LT-01105 Vilnius |
| LIETUVA/LITHUANIA |

Muitinės departamentas prie Lietuvos Respublikos finansų ministerijos

A. Jakšto g. 1/25

LT-01105 Vilnius

LIETUVA/LITHUANIA

LUXEMBOURG

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Direction des douanes et accises |
| --- |
| B.P. 1605 |
| 1016 Luxembourg |
| LUXEMBOURG |

Direction des douanes et accises

B.P. 1605

1016 Luxembourg

LUXEMBOURG

MALTA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Binding Tariff Information Unit |
| --- |
| Customs Department |
| Customs House |
| Lascaris Wharf |
| Valletta |
| VLT 1920 |
| MALTA |

Binding Tariff Information Unit

Customs Department

Customs House

Lascaris Wharf

Valletta

VLT 1920

MALTA

NETHERLANDS

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Belastingdienst/Douane Rotterdam/kantoor Laan op Zuid |
| --- |
| t.a.v. Afdeling bindende tarief inlichtingen |
| Postbus 50966 |
| 3007 BJ Rotterdam |
| NEDERLAND |

Belastingdienst/Douane Rotterdam/kantoor Laan op Zuid

t.a.v. Afdeling bindende tarief inlichtingen

Postbus 50966

3007 BJ Rotterdam

NEDERLAND

POLAND

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Izba Celna w Warszawie |
| --- |
| ul. Erazma Ciołka 14A |
| 01-443 Warszawa |
| POLSKA/POLAND |

Izba Celna w Warszawie

ul. Erazma Ciołka 14A

01-443 Warszawa

POLSKA/POLAND

PORTUGAL

Customs authorities designated for the purpose of issuing binding tariff information

| Direcção-Geral das Alfândegas e dos Impostos Especiais sobre o Consumo |
| --- |
| Direcção de Serviços de Tributação Aduaneira |
| Rua Terreiro do Trigo |
| Edifício da Alfândega |
| 1149-060 Lisboa |
| PORTUGAL |

Direcção-Geral das Alfândegas e dos Impostos Especiais sobre o Consumo

Direcção de Serviços de Tributação Aduaneira

Rua Terreiro do Trigo

Edifício da Alfândega

1149-060 Lisboa

PORTUGAL

Customs authorities designated for the purpose of receiving applications for binding tariff information

All customs offices

ROMANIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Autoritatea Națională a Vămilor |
| --- |
| Strada Matei Millo nr. 13, sector 1 |
| București |
| ROMÂNIA |

Autoritatea Națională a Vămilor

Strada Matei Millo nr. 13, sector 1

București

ROMÂNIA

SLOVAKIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Colný úrad Bratislava |
| --- |
| Oddelenie colných tarif |
| Miletičova 42 |
| 824 59 Bratislava |
| SLOVENSKO/SLOVAKIA |

Colný úrad Bratislava

Oddelenie colných tarif

Miletičova 42

824 59 Bratislava

SLOVENSKO/SLOVAKIA

SLOVENIA

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Republika Slovenija |
| --- |
| Ministrstvo za finance |
| Carinska uprava Republike Slovenije |
| Generalni carinski urad |
| Šmartinska 55 |
| SI-1523 Ljubljana |
| SLOVENIJA |

Republika Slovenija

Ministrstvo za finance

Carinska uprava Republike Slovenije

Generalni carinski urad

Šmartinska 55

SI-1523 Ljubljana

SLOVENIJA

SPAIN

Customs authorities designated for the purpose of issuing binding tariff information

| Departamento de Aduanas e Impuestos Especiales |
| --- |
| Avda. Llano Castellano, 17 |
| 28071 Madrid |
| ESPAÑA |

Departamento de Aduanas e Impuestos Especiales

Avda. Llano Castellano, 17

28071 Madrid

ESPAÑA

Customs authorities designated for the purpose of receiving applications for binding tariff information

All public Administration offices

SWEDEN

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| Tullverket |
| --- |
| Box 12854 |
| SE-112 98 Stockholm |
| SVERIGE |

Tullverket

Box 12854

SE-112 98 Stockholm

SVERIGE

UNITED KINGDOM

Customs authorities designated for the purpose of receiving applications and issuing binding tariff information

| HM Revenue and Customs |
| --- |
| Customs and International (C&I), Duty Liability Team |
| 10th Floor, Alexander House |
| 21 Victoria Avenue |
| Southend-on-Sea |
| Essex |
| SS99 1AA |
| UNITED KINGDOM |

HM Revenue and Customs

Customs and International (C&I), Duty Liability Team

10th Floor, Alexander House

21 Victoria Avenue

Southend-on-Sea

Essex

SS99 1AA

UNITED KINGDOM

---

(1)  OJ L 253, 11.10.1993, p. 1.

(2)  OJ L 62, 1.3.2007, p. 6-7.

---

NOTICES CONCERNING THE EUROPEAN ECONOMIC AREA

Commission

| 24.9.2009 | EN | Official Journal of the European Union | C 230/16 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/16

---

Authorisation of State aid pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part 1 of Protocol 3 to the Surveillance and Court Agreement

2009/C 230/06

The EFTA Surveillance Authority raises no objections to the following measure:

| Date of adoption of the decision | : | 22 April 2009 |
| --- | --- | --- |
| Case number | : | 65613 |
| EFTA State | : | Norway |
| Title (and/or name of the beneficiary) | : | Investment in infrastructure at Skien — Geiteryggen Airport |
| Budget | : | NOK 32,875 million (approximately EUR 3,79 million) |
| Economic sectors | : | Aviation sector |
| Name and address of the granting authority | : | Municipality of Skien |
| Postboks 158 |
| NO-3701 Skien |
| NORWAY |

Date of adoption of the decision

:

22 April 2009

Case number

:

65613

EFTA State

:

Norway

Title (and/or name of the beneficiary)

:

Investment in infrastructure at Skien — Geiteryggen Airport

Budget

:

NOK 32,875 million (approximately EUR 3,79 million)

Economic sectors

:

Aviation sector

Name and address of the granting authority

:

Municipality of Skien

Postboks 158

NO-3701 Skien

NORWAY

The authentic text of the decision, from which all confidential information has been removed, can be found on the EFTA Surveillance Authority’s website:

http://www.eftasurv.int/fieldsofwork/fieldstateaid/stateaidregistry/

---

| 24.9.2009 | EN | Official Journal of the European Union | C 230/17 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/17

---

Authorisation of State aid pursuant to Article 61 of the EEA Agreement and Article 1(3) in Part 1 of Protocol 3 to the Surveillance and Court Agreement

2009/C 230/07

The EFTA Surveillance Authority raises no objections to the following State aid measure:

| Date of adoption of the decision | : | 31.3.2009 |
| --- | --- | --- |
| Case number | : | 65913 |
| EFTA State | : | Norway |
| Title | : | Norwegian Special Tax System for Shipping — Amendments |
| Legal basis | : | Article 61(3)(c) EEA |
| Type of measure | : | Aid scheme |
| Objective | : | Promotion of the maritime sector |
| Form of aid | : | Tax exemptions |
| Budget | : | Approx. EUR 220 000 000 |
| Duration | : | Until 2017 |
| Economic sectors | : | Maritime transport |
| Name and address of the granting authority | : | Ministry of Finance |
| P.O. Box 8008 Dep |
| N-0030 Oslo |
| NORWAY |

Date of adoption of the decision

:

31.3.2009

Case number

:

65913

EFTA State

:

Norway

Title

:

Norwegian Special Tax System for Shipping — Amendments

Legal basis

:

Article 61(3)(c) EEA

Type of measure

:

Aid scheme

Objective

:

Promotion of the maritime sector

Form of aid

:

Tax exemptions

Budget

:

Approx. EUR 220 000 000

Duration

:

Until 2017

Economic sectors

:

Maritime transport

Name and address of the granting authority

:

Ministry of Finance

P.O. Box 8008 Dep

N-0030 Oslo

NORWAY

The authentic text of the decision, from which all confidential information has been removed, can be found on the EFTA Surveillance Authority’s website:

http://www.eftasurv.int/fieldsofwork/fieldstateaid/stateaidregistry/

---

Standing Committee of the EFTA States

| 24.9.2009 | EN | Official Journal of the European Union | C 230/18 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/18

---

Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008

2009/C 230/08

Subcommittee I on the free movement of goods

To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2008, at their meeting on 24 April 2009:

| Annex I | List of new marketing authorisations |
| --- | --- |
| Annex II | List of renewed marketing authorisations |
| Annex III | List of extended marketing authorisations |
| Annex IV | List of withdrawn marketing authorisations |
| Annex V | List of suspended marketing authorisations |

Annex I

List of new marketing authorisations

Annex II

List of renewed marketing authorisations

Annex III

List of extended marketing authorisations

Annex IV

List of withdrawn marketing authorisations

Annex V

List of suspended marketing authorisations

---

ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/06/380/001 | Prezista | Liechtenstein | 31.12.2008 |
| EU/1/08/444/001/NO-008/NO | Ratiograstim | Norway | 2.10.2008 |
| EU/1/08/444/001-008 | Ratiograstim | Liechtenstein | 31.10.2008 |
| EU/1/08/444/001-008/IS | Ratiograstim | Iceland | 24.10.2008 |
| EU/1/08/445/001/NO-008/NO | Tevagrastim | Norway | 8.10.2008 |
| EU/1/08/445/001-008 | Tevagrastim | Liechtenstein | 31.10.2008 |
| EU/1/08/445/001-008/IS | Tevagrastim | Iceland | 24.10.2008 |
| EU/1/08/446/001/NO-002/NO | Bridion | Norway | 12.9.2008 |
| EU/1/08/449/001/NO-008/NO | Filgrastim | Norway | 8.10.2008 |
| EU/1/08/449/001-008 | Filgrastim Ratiopharm | Liechtenstein | 31.10.2008 |
| EU/1/08/449/001-008/IS | Filgrastim Ratiopharm | Iceland | 24.10.2008 |
| EU/1/08/450/001/NO-008/NO | Biograstim | Norway | 2.10.2008 |
| EU/1/08/450/001-008 | Biograstim | Liechtenstein | 31.10.2008 |
| EU/1/08/450/001-008/IS | Biograstim | Iceland | 24.10.2008 |
| EU/1/08/452/001/NO | Pandemrix | Norway | 6.8.2008 |
| EU/1/08/453/001/NO | Prepandemrix | Norway | 18.9.2008 |
| EU/1/08/455/001/NO-014/NO | Janumet | Norway | 5.8.2008 |
| EU/1/08/455/001-014 | Janumet | Liechtenstein | 31.8.2008 |
| EU/1/08/455/001-014/IS | Janumet | Iceland | 5.9.2008 |
| EU/1/08/456/001/NO-014/NO | Velmetia | Norway | 5.8.2008 |
| EU/1/08/456/001-014 | Velmetia | Liechtenstein | 31.8.2008 |
| EU/1/08/456/001-014/IS | Velmetia | Iceland | 5.9.2008 |
| EU/1/08/457/001/NO-014/NO | Efficib | Norway | 5.8.2008 |
| EU/1/08/457/001-014 | Efficib | Liechtenstein | 31.8.2008 |
| EU/1/08/457/001-014/IS | Efficib | Iceland | 5.9.2008 |
| EU/1/08/458/001/NO-011/NO | Trevaclyn | Norway | 29.7.2008 |
| EU/1/08/458/001-011 | Trevaclyn | Liechtenstein | 31.8.2008 |
| EU/1/08/458/001-011/IS | Trevaclyn | Iceland | 25.7.2008 |
| EU/1/08/459/001/NO-011/NO | Tredaptive | Norway | 29.7.2008 |
| EU/1/08/459/001-011 | Tredaptive | Liechtenstein | 31.8.2008 |
| EU/1/08/459/001-011/IS | Tredaptive | Iceland | 25.7.2008 |
| EU/1/08/460/001/NO-011/NO | Pelzont | Norway | 29.7.2008 |
| EU/1/08/460/001-011 | Pelzont | Liechtenstein | 31.8.2008 |
| EU/1/08/460/001-011/IS | Pelzont | Iceland | 25.7.2008 |
| EU/1/08/461/001 | Firazyr (orphan drug) | Liechtenstein | 31.8.2008 |
| EU/1/08/461/001/IS | Firazyr | Iceland | 25.7.2008 |
| EU/1/08/461/001/NO | Firazyr | Norway | 25.8.2008 |
| EU/1/08/462/001-006/IS | Latixa | Iceland | 28.7.2008 |
| EU/1/08/463/001/NO-003/NO | Relistor | Norway | 11.7.2008 |
| EU/1/08/463/001-003 | Relistor | Liechtenstein | 31.8.2008 |
| EU/1/08/463/001-003/IS | Relistor | Iceland | 24.7.2008 |
| EU/1/08/464/001/NO-017/NO | Clopidogrel BMS | Norway | 7.8.2008 |
| EU/1/08/464/001-017 | Clopidogrel BMS | Liechtenstein | 31.8.2008 |
| EU/1/08/464/001-017/IS | Clopidogrel BMS | Iceland | 22.9.2008 |
| EU/1/08/465/001/NO-017/NO | Clopidogrel Winthrop | Norway | 7.8.2008 |
| EU/1/08/465/001-017 | Clopidogrel Winthrop | Liechtenstein | 31.8.2008 |
| EU/1/08/465/001-017/IS | Clopidogrel Winthrop | Iceland | 12.9.2008 |
| EU/1/08/466/001-002 | Bridion | Liechtenstein | 31.8.2008 |
| EU/1/08/466/001-002/IS | Bridion | Iceland | 4.9.2008 |
| EU/1/08/467/001 | Doribax | Liechtenstein | 31.8.2008 |
| EU/1/08/467/001/IS | Doribax | Iceland | 8.9.2008 |
| EU/1/08/467/001/NO | Doribax | Norway | 1.9.2008 |
| EU/1/08/468/001 | Intelence | Liechtenstein | 31.10.2008 |
| EU/1/08/468/001/IS | Intelence | Iceland | 26.9.2008 |
| EU/1/08/468/001/NO | Intelence | Norway | 18.9.2008 |
| EU/1/08/468/001/NO-025/NO | Oprymea | Norway | 9.10.2008 |
| EU/1/08/469/001-025 | Oprymea | Liechtenstein | 31.10.2008 |
| EU/1/08/469/001-025/IS | Oprymea | Iceland | 27.10.2008 |
| EU/1/08/470/001/NO-016/NO | Vimpat | Norway | 22.9.2008 |
| EU/1/08/470/001-015/IS | Vimpat | Iceland | 10.9.2008 |
| EU/1/08/470/001-016 | Vimpat | Liechtenstein | 31.10.2008 |
| EU/1/08/471/001/NO-012/NO | Duloxetine Boehringer Ingelheim | Norway | 29.10.2008 |
| EU/1/08/471/001-012 | Duloxetine Boehringer Ingelheim | Liechtenstein | 31.10.2008 |
| EU/1/08/471/001-012/IS | Duloxetine Boehringer Ingelheim | Iceland | 7.11.2008 |
| EU/1/08/472/001/NO-008/NO | Xarelto | Norway | 9.10.2008 |
| EU/1/08/472/001-008 | Xarelto | Liechtenstein | 31.10.2008 |
| EU/1/08/472/001-008/IS | Xarelto | Iceland | 15.10.2008 |
| EU/1/08/473/001/NO-003/NO | Evicel | Norway | 28.10.2008 |
| EU/1/08/473/001-003 | Evicel | Liechtenstein | 31.10.2008 |
| EU/1/08/473/001-003/IS | Evicel | Iceland | 17.11.2008 |
| EU/1/08/474/001-003 | Fluticasone furoate GSK | Liechtenstein | 31.10.2008 |
| EU/1/08/475/001/NO-034/NO | Olanzapine Mylan | Norway | 29.10.2008 |
| EU/1/08/475/001-034 | Olanzapine Mylan | Liechtenstein | 31.10.2008 |
| EU/1/08/475/001-034/IS | Olanzapine Mylan | Iceland | 21.11.2008 |
| EU/1/08/476/001/NO-004/NO | Tadalafil | Norway | 23.10.2008 |
| EU/1/08/476/001-004 | Tadalafil Lilly | Liechtenstein | 31.10.2008 |
| EU/1/08/477/001 | Ceplene (orphan) | Liechtenstein | 31.10.2008 |
| EU/1/08/477/001/IS | Ceplene | Iceland | 19.11.2008 |
| EU/1/08/478/001 | Prepandemic influenza vaccine (H5N1) | Liechtenstein | 31.10.2008 |
| EU/1/08/478/001/IS | Prepandemic influenza vaccine (H5N1) | Iceland | 24.10.2008 |
| EU/1/08/478/001/NO | Prepandemic influenza vaccine | Norway | 4.12.2008 |
| EU/1/08/479/001/NO-003/NO | Zypadhera | Norway | 16.12.2008 |
| EU/1/08/479/001-003 | Zypadhera | Liechtenstein | 31.12.2008 |
| EU/1/08/479/001-003/IS | Zypadhera | Iceland | 16.12.2008 |
| EU/1/08/480/001-018 | Irbesartan Krka | Liechtenstein | 31.12.2008 |
| EU/1/08/481/001-003 | Kuvan (orphan drug) | Liechtenstein | 31.12.2008 |
| EU/1/08/482/001-002 | Azarga | Liechtenstein | 31.12.2008 |
| EU/1/08/483/001-018 | Zomarist | Liechtenstein | 31.12.2008 |
| EU/1/08/484/001-018 | Vildagliptin | Liechtenstein | 31.12.2008 |
| EU/1/08/485/001/NO-011/NO | Jalra | Norway | 4.12.2008 |
| EU/1/08/485/001-011 | Jalra | Liechtenstein | 31.12.2008 |
| EU/1/08/485/001-011/IS | Jalra | Iceland | 16.12.2008 |
| EU/1/08/486/001/NO-011/NO | Xiliarx | Norway | 4.12.2008 |
| EU/1/08/486/001-011 | Xiliarx | Liechtenstein | 31.12.2008 |
| EU/1/08/486/001-011/IS | Xiliarx | Iceland | 16.12.2008 |
| EU/1/08477/001/NO | Ceplene | Norway | 28.10.2008 |
| EU/2/08/080/001-004 | Reconcile | Liechtenstein | 31.8.2008 |
| EU/2/08/080/001-004/IS | Reconcile | Iceland | 5.8.2008 |
| EU/2/08/081/001-003/IS | Posatex | Iceland | 10.9.2008 |
| EU/2/08/082/001-003 | Zactran | Liechtenstein | 31.8.2008 |
| EU/2/08/082/001-003/IS | Zactran | Iceland | 8.9.2008 |
| EU/2/08/083/001 | Equioxx | Liechtenstein | 31.8.2008 |
| EU/2/08/084/001/NO-005/NO | Trocoxil | Norway | 15.10.2008 |
| EU/2/08/084/001-005 | Trocoxil | Liechtenstein | 31.10.2008 |
| EU/2/08/084/001-005/IS | Trocoxil | Iceland | 24.10.2008 |
| EU/2/08/085/001 | Easotic | Liechtenstein | 31.12.2008 |
| EU/2/08/086/001/NO-003/NO | Duvaxyn WNV | Norway | 18.12.2008 |
| EU/2/08/086/001-003 | Duvaxyn WNV | Liechtenstein | 31.12.2008 |
| EU/2/08/087/001-002 | Masivet | Liechtenstein | 31.12.2008 |
| EU/2/08/087/001-002/IS | Masivet | Iceland | 12.12.2008 |
| EU/2/08/088/001-004 | Acticam | Liechtenstein | 31.12.2008 |

EU-Number

Product

Country

Date of authorisation

EU/1/06/380/001

Prezista

Liechtenstein

31.12.2008

EU/1/08/444/001/NO-008/NO

Ratiograstim

Norway

2.10.2008

EU/1/08/444/001-008

Ratiograstim

Liechtenstein

31.10.2008

EU/1/08/444/001-008/IS

Ratiograstim

Iceland

24.10.2008

EU/1/08/445/001/NO-008/NO

Tevagrastim

Norway

8.10.2008

EU/1/08/445/001-008

Tevagrastim

Liechtenstein

31.10.2008

EU/1/08/445/001-008/IS

Tevagrastim

Iceland

24.10.2008

EU/1/08/446/001/NO-002/NO

Bridion

Norway

12.9.2008

EU/1/08/449/001/NO-008/NO

Filgrastim

Norway

8.10.2008

EU/1/08/449/001-008

Filgrastim Ratiopharm

Liechtenstein

31.10.2008

EU/1/08/449/001-008/IS

Filgrastim Ratiopharm

Iceland

24.10.2008

EU/1/08/450/001/NO-008/NO

Biograstim

Norway

2.10.2008

EU/1/08/450/001-008

Biograstim

Liechtenstein

31.10.2008

EU/1/08/450/001-008/IS

Biograstim

Iceland

24.10.2008

EU/1/08/452/001/NO

Pandemrix

Norway

6.8.2008

EU/1/08/453/001/NO

Prepandemrix

Norway

18.9.2008

EU/1/08/455/001/NO-014/NO

Janumet

Norway

5.8.2008

EU/1/08/455/001-014

Janumet

Liechtenstein

31.8.2008

EU/1/08/455/001-014/IS

Janumet

Iceland

5.9.2008

EU/1/08/456/001/NO-014/NO

Velmetia

Norway

5.8.2008

EU/1/08/456/001-014

Velmetia

Liechtenstein

31.8.2008

EU/1/08/456/001-014/IS

Velmetia

Iceland

5.9.2008

EU/1/08/457/001/NO-014/NO

Efficib

Norway

5.8.2008

EU/1/08/457/001-014

Efficib

Liechtenstein

31.8.2008

EU/1/08/457/001-014/IS

Efficib

Iceland

5.9.2008

EU/1/08/458/001/NO-011/NO

Trevaclyn

Norway

29.7.2008

EU/1/08/458/001-011

Trevaclyn

Liechtenstein

31.8.2008

EU/1/08/458/001-011/IS

Trevaclyn

Iceland

25.7.2008

EU/1/08/459/001/NO-011/NO

Tredaptive

Norway

29.7.2008

EU/1/08/459/001-011

Tredaptive

Liechtenstein

31.8.2008

EU/1/08/459/001-011/IS

Tredaptive

Iceland

25.7.2008

EU/1/08/460/001/NO-011/NO

Pelzont

Norway

29.7.2008

EU/1/08/460/001-011

Pelzont

Liechtenstein

31.8.2008

EU/1/08/460/001-011/IS

Pelzont

Iceland

25.7.2008

EU/1/08/461/001

Firazyr (orphan drug)

Liechtenstein

31.8.2008

EU/1/08/461/001/IS

Firazyr

Iceland

25.7.2008

EU/1/08/461/001/NO

Firazyr

Norway

25.8.2008

EU/1/08/462/001-006/IS

Latixa

Iceland

28.7.2008

EU/1/08/463/001/NO-003/NO

Relistor

Norway

11.7.2008

EU/1/08/463/001-003

Relistor

Liechtenstein

31.8.2008

EU/1/08/463/001-003/IS

Relistor

Iceland

24.7.2008

EU/1/08/464/001/NO-017/NO

Clopidogrel BMS

Norway

7.8.2008

EU/1/08/464/001-017

Clopidogrel BMS

Liechtenstein

31.8.2008

EU/1/08/464/001-017/IS

Clopidogrel BMS

Iceland

22.9.2008

EU/1/08/465/001/NO-017/NO

Clopidogrel Winthrop

Norway

7.8.2008

EU/1/08/465/001-017

Clopidogrel Winthrop

Liechtenstein

31.8.2008

EU/1/08/465/001-017/IS

Clopidogrel Winthrop

Iceland

12.9.2008

EU/1/08/466/001-002

Bridion

Liechtenstein

31.8.2008

EU/1/08/466/001-002/IS

Bridion

Iceland

4.9.2008

EU/1/08/467/001

Doribax

Liechtenstein

31.8.2008

EU/1/08/467/001/IS

Doribax

Iceland

8.9.2008

EU/1/08/467/001/NO

Doribax

Norway

1.9.2008

EU/1/08/468/001

Intelence

Liechtenstein

31.10.2008

EU/1/08/468/001/IS

Intelence

Iceland

26.9.2008

EU/1/08/468/001/NO

Intelence

Norway

18.9.2008

EU/1/08/468/001/NO-025/NO

Oprymea

Norway

9.10.2008

EU/1/08/469/001-025

Oprymea

Liechtenstein

31.10.2008

EU/1/08/469/001-025/IS

Oprymea

Iceland

27.10.2008

EU/1/08/470/001/NO-016/NO

Vimpat

Norway

22.9.2008

EU/1/08/470/001-015/IS

Vimpat

Iceland

10.9.2008

EU/1/08/470/001-016

Vimpat

Liechtenstein

31.10.2008

EU/1/08/471/001/NO-012/NO

Duloxetine Boehringer Ingelheim

Norway

29.10.2008

EU/1/08/471/001-012

Duloxetine Boehringer Ingelheim

Liechtenstein

31.10.2008

EU/1/08/471/001-012/IS

Duloxetine Boehringer Ingelheim

Iceland

7.11.2008

EU/1/08/472/001/NO-008/NO

Xarelto

Norway

9.10.2008

EU/1/08/472/001-008

Xarelto

Liechtenstein

31.10.2008

EU/1/08/472/001-008/IS

Xarelto

Iceland

15.10.2008

EU/1/08/473/001/NO-003/NO

Evicel

Norway

28.10.2008

EU/1/08/473/001-003

Evicel

Liechtenstein

31.10.2008

EU/1/08/473/001-003/IS

Evicel

Iceland

17.11.2008

EU/1/08/474/001-003

Fluticasone furoate GSK

Liechtenstein

31.10.2008

EU/1/08/475/001/NO-034/NO

Olanzapine Mylan

Norway

29.10.2008

EU/1/08/475/001-034

Olanzapine Mylan

Liechtenstein

31.10.2008

EU/1/08/475/001-034/IS

Olanzapine Mylan

Iceland

21.11.2008

EU/1/08/476/001/NO-004/NO

Tadalafil

Norway

23.10.2008

EU/1/08/476/001-004

Tadalafil Lilly

Liechtenstein

31.10.2008

EU/1/08/477/001

Ceplene (orphan)

Liechtenstein

31.10.2008

EU/1/08/477/001/IS

Ceplene

Iceland

19.11.2008

EU/1/08/478/001

Prepandemic influenza vaccine (H5N1)

Liechtenstein

31.10.2008

EU/1/08/478/001/IS

Prepandemic influenza vaccine (H5N1)

Iceland

24.10.2008

EU/1/08/478/001/NO

Prepandemic influenza vaccine

Norway

4.12.2008

EU/1/08/479/001/NO-003/NO

Zypadhera

Norway

16.12.2008

EU/1/08/479/001-003

Zypadhera

Liechtenstein

31.12.2008

EU/1/08/479/001-003/IS

Zypadhera

Iceland

16.12.2008

EU/1/08/480/001-018

Irbesartan Krka

Liechtenstein

31.12.2008

EU/1/08/481/001-003

Kuvan (orphan drug)

Liechtenstein

31.12.2008

EU/1/08/482/001-002

Azarga

Liechtenstein

31.12.2008

EU/1/08/483/001-018

Zomarist

Liechtenstein

31.12.2008

EU/1/08/484/001-018

Vildagliptin

Liechtenstein

31.12.2008

EU/1/08/485/001/NO-011/NO

Jalra

Norway

4.12.2008

EU/1/08/485/001-011

Jalra

Liechtenstein

31.12.2008

EU/1/08/485/001-011/IS

Jalra

Iceland

16.12.2008

EU/1/08/486/001/NO-011/NO

Xiliarx

Norway

4.12.2008

EU/1/08/486/001-011

Xiliarx

Liechtenstein

31.12.2008

EU/1/08/486/001-011/IS

Xiliarx

Iceland

16.12.2008

EU/1/08477/001/NO

Ceplene

Norway

28.10.2008

EU/2/08/080/001-004

Reconcile

Liechtenstein

31.8.2008

EU/2/08/080/001-004/IS

Reconcile

Iceland

5.8.2008

EU/2/08/081/001-003/IS

Posatex

Iceland

10.9.2008

EU/2/08/082/001-003

Zactran

Liechtenstein

31.8.2008

EU/2/08/082/001-003/IS

Zactran

Iceland

8.9.2008

EU/2/08/083/001

Equioxx

Liechtenstein

31.8.2008

EU/2/08/084/001/NO-005/NO

Trocoxil

Norway

15.10.2008

EU/2/08/084/001-005

Trocoxil

Liechtenstein

31.10.2008

EU/2/08/084/001-005/IS

Trocoxil

Iceland

24.10.2008

EU/2/08/085/001

Easotic

Liechtenstein

31.12.2008

EU/2/08/086/001/NO-003/NO

Duvaxyn WNV

Norway

18.12.2008

EU/2/08/086/001-003

Duvaxyn WNV

Liechtenstein

31.12.2008

EU/2/08/087/001-002

Masivet

Liechtenstein

31.12.2008

EU/2/08/087/001-002/IS

Masivet

Iceland

12.12.2008

EU/2/08/088/001-004

Acticam

Liechtenstein

31.12.2008

---

ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/00/162/003/NO-005/NO;
  EU/1/00/162/009/NO-011/NO;
  EU/1/00/162/015/NO-017/NO;
  EU/1/00/162/019/NO-021/NO | Prandin | Norway | 15.8.2008 |
| EU/1/00/162/003-005, 009-011, 015-017, 019-021 | Prandin | Liechtenstein | 31.8.2008 |
| EU/1/00/162/003-005, 009-011, 015-017, 019-021/IS | Prandin | Iceland | 26.9.2008 |
| EU/1/03/247/001/NO-002/NO | Forsteo | Norway | 1.7.2008 |
| EU/1/03/252/001/NO-003/NO | Fuzeon | Norway | 12.8.2008 |
| EU/1/03/252/001-003 | Fuzeon | Liechtenstein | 31.8.2008 |
| EU/1/03/252/001-003/IS | Fuzeon | Iceland | 5.8.2008 |
| EU/1/03/254/002 | Busilvex | Liechtenstein | 31.8.2008 |
| EU/1/03/254/002/IS | Busilvex | Iceland | 10.7.2008 |
| EU/1/03/254/002/NO | Busilvex | Norway | 12.8.2008 |
| EU/1/03/255/001/NO-006/NO | Ventavis | Norway | 29.9.2008 |
| EU/1/03/255/001-006 | Ventavis | Liechtenstein | 31.10.2008 |
| EU/1/03/255/001-006/IS | Ventavis | Iceland | 19.10.2008 |
| EU/1/03/256/001/NO-010/NO | Humira | Norway | 25.9.2008 |
| EU/1/03/256/001-010 | Humira | Liechtenstein | 31.10.2008 |
| EU/1/03/256/001-010/IS | Humira | Iceland | 24.10.2008 |
| EU/1/03/258/001/NO-022/NO | Avandamet | Norway | 9.9.2008 |
| EU/1/03/258/001-022 | Avandamet | Liechtenstein | 31.8.2008 |
| EU/1/03/258/001-022/IS | Avandamet | Iceland | 20.10.2008 |
| EU/1/03/259/001/NO-006/NO | Onsenal | Norway | 6.11.2008 |
| EU/1/03/259/001-006 | Onsenal | Liechtenstein | 31.10.2008 |
| EU/1/03/259/001-006/IS | Onsenal | Iceland | 12.12.2008 |
| EU/1/03/260/001/NO-023/NO | Stalevo | Norway | 9.10.2008 |
| EU/1/03/260/001-023 | Stalevo | Liechtenstein | 31.10.2008 |
| EU/1/03/260/001-023/IS | Stalevo | Iceland | 22.10.2008 |
| EU/1/03/261/001/NO-003/NO | Emtriva | Norway | 10.11.2008 |
| EU/1/03/261/001-003 | Emtriva | Liechtenstein | 31.10.2008 |
| EU/1/03/261/001-003/IS | Emtriva | Iceland | 27.10.2008 |
| EU/1/03/262/001/NO-008/NO | Emend | Norway | 8.10.2008 |
| EU/1/03/262/001-008 | Emend | Liechtenstein | 31.10.2008 |
| EU/1/03/262/001-008/IS | Emend | Iceland | 27.10.2008 |
| EU/1/03/269/001 | Faslodex | Liechtenstein | 31.12.2008 |
| EU/1/06/367/001-012 | Diacomit | Liechtenstein | 31.12.2008 |
| EU/1/06/367/001-012/IS | Diacomit | Iceland | 18.12.2008 |
| EU/1/07/436/001-002 | Isentress | Liechtenstein | 31.12.2008 |
| EU/1/07/436/001-002/IS | Isentress | Iceland | 18.12.2008 |
| EU/1/98/064/001 | Pylobactell | Liechtenstein | 31.8.2008 |
| EU/1/98/064/001/IS | Pylobactell | Iceland | 19.10.2008 |
| EU/1/98/064/001/NO | Pylobactell | Norway | 8.12.2008 |
| EU/1/98/065/001/NO-002/NO | Optison | Norway | 18.9.2008 |
| EU/1/98/065/001-002/IS | Optison | Iceland | 10.7.2008 |
| EU/1/98/069/001a/NO-007a/NO;
  EU/1/98/069/001b/NO-007b/NO
  EU/1/98/069/008/NO-010/NO | Plavix | Norway | 2.7.2008 |
| EU/1/98/070/001a/NO-007a/NO;
  EU/1/98/070/001b/NO-007b/NO;
  EU/1/98/070/008/NO-010/NO | Iscover | Norway | 2.7.2008 |
| EU/1/98/071/001/NO-006/NO | Xenical | Norway | 9.9.2008 |
| EU/1/98/071/001-006/IS | Xenical | Iceland | 10.7.2008 |
| EU/1/98/073/001/NO-004/NO | Evista | Norway | 19.9.2008 |
| EU/1/98/073/001-004 | Evista | Liechtenstein | 31.8.2008 |
| EU/1/98/073/001-004/IS | Evista | Iceland | 22.10.2008 |
| EU/1/98/074/001/NO-004/NO | Optruma | Norway | 19.9.2008 |
| EU/1/98/074/001-004 | Optruma | Liechtenstein | 31.8.2008 |
| EU/1/98/074/001-004/IS | Optruma | Iceland | 22.10.2008 |
| EU/1/98/076/004/NO-006/NO,
  EU/1/98/076/011/NO-013/NO,
  EU/1/98/076/018/NO-020/NO,
  EU/1/98/076/022/NO-024/NO | NovoNorm | Norway | 15.8.2008 |
| EU/1/98/076/004-006, 011-013, 018-020, 022-024 | NovoNorm | Liechtenstein | 31.8.2008 |
| EU/1/98/076/004-006, 011-013, 018-020, 022-024/IS | NovoNorm | Iceland | 25.9.2008 |
| EU/1/98/077/002/NO-004/NO;
  EU/1/98/077/006/NO-008/NO;
  EU/1/98/077/010/NO-019/NO | Viagra | Norway | 24.9.2008 |
| EU/1/98/077/002-004, 006-008, 010-019/IS | Viagra | Iceland | 25.10.2008 |
| EU/1/98/080/001 | Aldara | Liechtenstein | 31.10.2008 |
| EU/1/98/080/001/IS | Aldara | Iceland | 19.11.2008 |
| EU/1/98/080/001/NO | Aldara | Norway | 9.10.2008 |
| EU/1/98/081/001/NO-004/NO | Comtan | Norway | 29.9.2008 |
| EU/1/98/081/001-004 | Comtan | Liechtenstein | 31.10.2008 |
| EU/1/98/081/001-004/IS | Comtan | Iceland | 21.10.2008 |
| EU/1/98/082/001/NO-003/NO;
  EU/1/98/082/005/NO | Comtess | Norway | 29.9.2008 |
| EU/1/98/082/001-003, 005 | Comtess | Liechtenstein | 31.10.2008 |
| EU/1/98/082/001-003, 005/IS | Comtess | Iceland | 21.10.2008 |
| EU/1/98/084/001/NO-002/NO | Simulect | Norway | 11.11.2008 |
| EU/1/98/084/001-002 | Simulect | Liechtenstein | 31.10.2008 |
| EU/1/98/084/001-002/IS | Simulect | Iceland | 7.11.2008 |
| EU/1/98/085/001/NO-034/NO | Karvezide | Norway | 28.10.2008 |
| EU/1/98/085/001-034 | Karvezide | Liechtenstein | 31.12.2008 |
| EU/1/98/085/001-034/IS | Karvezide | Iceland | 28.10.2008 |
| EU/1/98/086/001/NO-034/NO | CoAprovel | Norway | 28.10.2008 |
| EU/1/98/086/001-034 | CoAprovel | Liechtenstein | 31.12.2008 |
| EU/1/98/086/001-034/IS | CoAprovel | Iceland | 28.10.2008 |
| EU/1/98/089/001-022 | Pritor | Liechtenstein | 31.12.2008 |
| EU/1/98/089/001-022/IS | Pritor | Iceland | 18.12.2008 |
| EU/1/98/090/001-020 | Micardis | Liechtenstein | 31.12.2008 |
| EU/1/98/090/001-020/IS | Micardis | Iceland | 18.12.2008 |
| EU/1/98/091/001-014 | Kinzalmono | Liechtenstein | 31.12.2008 |
| EU/1/98/091/001-014/IS | Kinzalmono | Iceland | 18.12.2008 |
| EU/2/03/040/001-002/IS | Gonazon | Iceland | 11.7.2008 |
| EU/2/03/041/001-005 | Draxxin | Liechtenstein | 31.10.2008 |
| EU/2/03/041/001-005/IS | Draxxin | Iceland | 27.10.2008 |
| EU/2/98/009/001/NO-006/NO | Suvaxyn Aujeszky | Norway | 18.12.2008 |
| EU/2/98/009/001-006 | Suvaxyn Aujeszky | Liechtenstein | 31.10.2008 |
| EU/2/99/011/001 | Locatim | Liechtenstein | 31.12.2008 |

EU-Number

Product

Country

Date of authorisation

EU/1/00/162/003/NO-005/NO;

EU/1/00/162/009/NO-011/NO;

EU/1/00/162/015/NO-017/NO;

EU/1/00/162/019/NO-021/NO

Prandin

Norway

15.8.2008

EU/1/00/162/003-005, 009-011, 015-017, 019-021

Prandin

Liechtenstein

31.8.2008

EU/1/00/162/003-005, 009-011, 015-017, 019-021/IS

Prandin

Iceland

26.9.2008

EU/1/03/247/001/NO-002/NO

Forsteo

Norway

1.7.2008

EU/1/03/252/001/NO-003/NO

Fuzeon

Norway

12.8.2008

EU/1/03/252/001-003

Fuzeon

Liechtenstein

31.8.2008

EU/1/03/252/001-003/IS

Fuzeon

Iceland

5.8.2008

EU/1/03/254/002

Busilvex

Liechtenstein

31.8.2008

EU/1/03/254/002/IS

Busilvex

Iceland

10.7.2008

EU/1/03/254/002/NO

Busilvex

Norway

12.8.2008

EU/1/03/255/001/NO-006/NO

Ventavis

Norway

29.9.2008

EU/1/03/255/001-006

Ventavis

Liechtenstein

31.10.2008

EU/1/03/255/001-006/IS

Ventavis

Iceland

19.10.2008

EU/1/03/256/001/NO-010/NO

Humira

Norway

25.9.2008

EU/1/03/256/001-010

Humira

Liechtenstein

31.10.2008

EU/1/03/256/001-010/IS

Humira

Iceland

24.10.2008

EU/1/03/258/001/NO-022/NO

Avandamet

Norway

9.9.2008

EU/1/03/258/001-022

Avandamet

Liechtenstein

31.8.2008

EU/1/03/258/001-022/IS

Avandamet

Iceland

20.10.2008

EU/1/03/259/001/NO-006/NO

Onsenal

Norway

6.11.2008

EU/1/03/259/001-006

Onsenal

Liechtenstein

31.10.2008

EU/1/03/259/001-006/IS

Onsenal

Iceland

12.12.2008

EU/1/03/260/001/NO-023/NO

Stalevo

Norway

9.10.2008

EU/1/03/260/001-023

Stalevo

Liechtenstein

31.10.2008

EU/1/03/260/001-023/IS

Stalevo

Iceland

22.10.2008

EU/1/03/261/001/NO-003/NO

Emtriva

Norway

10.11.2008

EU/1/03/261/001-003

Emtriva

Liechtenstein

31.10.2008

EU/1/03/261/001-003/IS

Emtriva

Iceland

27.10.2008

EU/1/03/262/001/NO-008/NO

Emend

Norway

8.10.2008

EU/1/03/262/001-008

Emend

Liechtenstein

31.10.2008

EU/1/03/262/001-008/IS

Emend

Iceland

27.10.2008

EU/1/03/269/001

Faslodex

Liechtenstein

31.12.2008

EU/1/06/367/001-012

Diacomit

Liechtenstein

31.12.2008

EU/1/06/367/001-012/IS

Diacomit

Iceland

18.12.2008

EU/1/07/436/001-002

Isentress

Liechtenstein

31.12.2008

EU/1/07/436/001-002/IS

Isentress

Iceland

18.12.2008

EU/1/98/064/001

Pylobactell

Liechtenstein

31.8.2008

EU/1/98/064/001/IS

Pylobactell

Iceland

19.10.2008

EU/1/98/064/001/NO

Pylobactell

Norway

8.12.2008

EU/1/98/065/001/NO-002/NO

Optison

Norway

18.9.2008

EU/1/98/065/001-002/IS

Optison

Iceland

10.7.2008

EU/1/98/069/001a/NO-007a/NO;

EU/1/98/069/001b/NO-007b/NO

EU/1/98/069/008/NO-010/NO

Plavix

Norway

2.7.2008

EU/1/98/070/001a/NO-007a/NO;

EU/1/98/070/001b/NO-007b/NO;

EU/1/98/070/008/NO-010/NO

Iscover

Norway

2.7.2008

EU/1/98/071/001/NO-006/NO

Xenical

Norway

9.9.2008

EU/1/98/071/001-006/IS

Xenical

Iceland

10.7.2008

EU/1/98/073/001/NO-004/NO

Evista

Norway

19.9.2008

EU/1/98/073/001-004

Evista

Liechtenstein

31.8.2008

EU/1/98/073/001-004/IS

Evista

Iceland

22.10.2008

EU/1/98/074/001/NO-004/NO

Optruma

Norway

19.9.2008

EU/1/98/074/001-004

Optruma

Liechtenstein

31.8.2008

EU/1/98/074/001-004/IS

Optruma

Iceland

22.10.2008

EU/1/98/076/004/NO-006/NO,

EU/1/98/076/011/NO-013/NO,

EU/1/98/076/018/NO-020/NO,

EU/1/98/076/022/NO-024/NO

NovoNorm

Norway

15.8.2008

EU/1/98/076/004-006, 011-013, 018-020, 022-024

NovoNorm

Liechtenstein

31.8.2008

EU/1/98/076/004-006, 011-013, 018-020, 022-024/IS

NovoNorm

Iceland

25.9.2008

EU/1/98/077/002/NO-004/NO;

EU/1/98/077/006/NO-008/NO;

EU/1/98/077/010/NO-019/NO

Viagra

Norway

24.9.2008

EU/1/98/077/002-004, 006-008, 010-019/IS

Viagra

Iceland

25.10.2008

EU/1/98/080/001

Aldara

Liechtenstein

31.10.2008

EU/1/98/080/001/IS

Aldara

Iceland

19.11.2008

EU/1/98/080/001/NO

Aldara

Norway

9.10.2008

EU/1/98/081/001/NO-004/NO

Comtan

Norway

29.9.2008

EU/1/98/081/001-004

Comtan

Liechtenstein

31.10.2008

EU/1/98/081/001-004/IS

Comtan

Iceland

21.10.2008

EU/1/98/082/001/NO-003/NO;

EU/1/98/082/005/NO

Comtess

Norway

29.9.2008

EU/1/98/082/001-003, 005

Comtess

Liechtenstein

31.10.2008

EU/1/98/082/001-003, 005/IS

Comtess

Iceland

21.10.2008

EU/1/98/084/001/NO-002/NO

Simulect

Norway

11.11.2008

EU/1/98/084/001-002

Simulect

Liechtenstein

31.10.2008

EU/1/98/084/001-002/IS

Simulect

Iceland

7.11.2008

EU/1/98/085/001/NO-034/NO

Karvezide

Norway

28.10.2008

EU/1/98/085/001-034

Karvezide

Liechtenstein

31.12.2008

EU/1/98/085/001-034/IS

Karvezide

Iceland

28.10.2008

EU/1/98/086/001/NO-034/NO

CoAprovel

Norway

28.10.2008

EU/1/98/086/001-034

CoAprovel

Liechtenstein

31.12.2008

EU/1/98/086/001-034/IS

CoAprovel

Iceland

28.10.2008

EU/1/98/089/001-022

Pritor

Liechtenstein

31.12.2008

EU/1/98/089/001-022/IS

Pritor

Iceland

18.12.2008

EU/1/98/090/001-020

Micardis

Liechtenstein

31.12.2008

EU/1/98/090/001-020/IS

Micardis

Iceland

18.12.2008

EU/1/98/091/001-014

Kinzalmono

Liechtenstein

31.12.2008

EU/1/98/091/001-014/IS

Kinzalmono

Iceland

18.12.2008

EU/2/03/040/001-002/IS

Gonazon

Iceland

11.7.2008

EU/2/03/041/001-005

Draxxin

Liechtenstein

31.10.2008

EU/2/03/041/001-005/IS

Draxxin

Iceland

27.10.2008

EU/2/98/009/001/NO-006/NO

Suvaxyn Aujeszky

Norway

18.12.2008

EU/2/98/009/001-006

Suvaxyn Aujeszky

Liechtenstein

31.10.2008

EU/2/99/011/001

Locatim

Liechtenstein

31.12.2008

---

ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of authorisation |
| --- | --- | --- | --- |
| EU/1/01/183/030-032 | HBVAXPRO | Liechtenstein | 31.10.2008 |
| EU/1/01/195/022-027 | Liprolog | Liechtenstein | 31.8.2008 |
| EU/1/01/195/022-027/IS | Liprolog | Iceland | 11.8.2008 |
| EU/1/02/214/011/NO-015/NO | Kinzalkomb | Norway | 15.9.2008 |
| EU/1/02/215/015/NO-021/NO | PritorPlus | Norway | 15.9.2008 |
| EU/1/03/255/006 | Ventavis | Liechtenstein | 31.8.2008 |
| EU/1/03/267/010 | Reyataz | Liechtenstein | 31.12.2008 |
| EU/1/04/291/003 | Raptiva | Liechtenstein | 31.10.2008 |
| EU/1/04/291/003/NO | Raptiva | Norway | 26.11.2008 |
| EU/1/04/305/002 | Truvada | Liechtenstein | 31.10.2008 |
| EU/1/04/305/002/NO | Truvada | Norway | 16.9.2008 |
| EU/1/05/330/005/NO-011/NO | Rotarix | Norway | 6.10.2008 |
| EU/1/05/330/005-011 | Rotarix | Liechtenstein | 31.10.2008 |
| EU/1/05/330/005-011/IS | Rotarix | Iceland | 27.9.2008 |
| EU/1/05/331/038/NO-055/NO | Neupro | Norway | 25.9.2008 |
| EU/1/05/331/038-055 | Neupro | Liechtenstein | 31.10.2008 |
| EU/1/05/331/038-055/IS | Neupro | Iceland | 15.10.2008 |
| EU/1/06/343/006-007 | Baraclude | Liechtenstein | 31.8.2008 |
| EU/1/06/356/007-009 | Exjade | Liechtenstein | 31.12.2008 |
| EU/1/06/360/012 | Champix | Liechtenstein | 31.8.2008 |
| EU/1/06/368/088/NO-142/NO | Insulin Human Winthrop | Norway | 28.11.2008 |
| EU/1/06/368/088-142 | Insulin Human Winthrop | Liechtenstein | 31.12.2008 |
| EU/1/07/386/011-012 | Toviaz | Liechtenstein | 31.8.2008 |
| EU/1/07/386/013-016 | Toviaz | Liechtenstein | 31.12.2008 |
| EU/1/07/392/002 | Circadin | Liechtenstein | 31.8.2008 |
| EU/1/07/394/007-009 | Optaflu | Liechtenstein | 31.8.2008 |
| EU/1/07/400/017/NO-021/NO | Mircera | Norway | 13.10.2008 |
| EU/1/07/400/017-020/IS | Mircera | Iceland | 17.10.2008 |
| EU/1/07/400/017-021 | Mircera | Liechtenstein | 31.10.2008 |
| EU/1/07/410/017-020 | Binocrit | Liechtenstein | 31.8.2008 |
| EU/1/07/411/017-020 | Epoetin alfa Hexal | Liechtenstein | 31.8.2008 |
| EU/1/07/412/017-020 | Abseamed | Liechtenstein | 31.8.2008 |
| EU/1/07/414/018 | Galvus | Liechtenstein | 31.10.2008 |
| EU/1/07/419/010-012 | Cervarix | Liechtenstein | 31.12.2008 |
| EU/1/07/431/020/NO-025/NO | Retacrit | Norway | 15.12.2008 |
| EU/1/07/431/020-025 | Retacrit | Liechtenstein | 31.12.2008 |
| EU/1/07/432/020-022 | Silapo | Liechtenstein | 31.8.2008 |
| EU/1/95/003/007/NO-008/NO | Betaferon | Norway | 13.11.2008 |
| EU/1/95/003/007-008 | Betaferon | Liechtenstein | 31.12.2008 |
| EU/1/97/030/140/NO-169/NO | Insuman | Norway | 1.12.2008 |
| EU/1/97/030/140-169 | Insuman | Liechtenstein | 31.12.2008 |
| EU/102/206/021/NO-035/NO | Arixtra | Norway | 8.9.2008 |
| EU/102/206/021-035 | Arixtra | Liechtenstein | 31.10.2008 |
| EU/2/02/033/002 | Dexdomitor | Liechtenstein | 31.8.2008 |
| EU/2/05/054/018/NO-031/NO | Profender | Norway | 24.9.2008 |
| EU/2/05/054/018-031 | Profender | Liechtenstein | 31.10.2008 |
| EU/2/05/054/018-031/IS | Profender | Iceland | 1.10.2008 |
| EU/2/06/058/004 | Flexicam | Liechtenstein | 31.12.2008 |
| EU/2/99/015/002 | Oxyglobin | Liechtenstein | 31.10.2008 |

EU-Number

Product

Country

Date of authorisation

EU/1/01/183/030-032

HBVAXPRO

Liechtenstein

31.10.2008

EU/1/01/195/022-027

Liprolog

Liechtenstein

31.8.2008

EU/1/01/195/022-027/IS

Liprolog

Iceland

11.8.2008

EU/1/02/214/011/NO-015/NO

Kinzalkomb

Norway

15.9.2008

EU/1/02/215/015/NO-021/NO

PritorPlus

Norway

15.9.2008

EU/1/03/255/006

Ventavis

Liechtenstein

31.8.2008

EU/1/03/267/010

Reyataz

Liechtenstein

31.12.2008

EU/1/04/291/003

Raptiva

Liechtenstein

31.10.2008

EU/1/04/291/003/NO

Raptiva

Norway

26.11.2008

EU/1/04/305/002

Truvada

Liechtenstein

31.10.2008

EU/1/04/305/002/NO

Truvada

Norway

16.9.2008

EU/1/05/330/005/NO-011/NO

Rotarix

Norway

6.10.2008

EU/1/05/330/005-011

Rotarix

Liechtenstein

31.10.2008

EU/1/05/330/005-011/IS

Rotarix

Iceland

27.9.2008

EU/1/05/331/038/NO-055/NO

Neupro

Norway

25.9.2008

EU/1/05/331/038-055

Neupro

Liechtenstein

31.10.2008

EU/1/05/331/038-055/IS

Neupro

Iceland

15.10.2008

EU/1/06/343/006-007

Baraclude

Liechtenstein

31.8.2008

EU/1/06/356/007-009

Exjade

Liechtenstein

31.12.2008

EU/1/06/360/012

Champix

Liechtenstein

31.8.2008

EU/1/06/368/088/NO-142/NO

Insulin Human Winthrop

Norway

28.11.2008

EU/1/06/368/088-142

Insulin Human Winthrop

Liechtenstein

31.12.2008

EU/1/07/386/011-012

Toviaz

Liechtenstein

31.8.2008

EU/1/07/386/013-016

Toviaz

Liechtenstein

31.12.2008

EU/1/07/392/002

Circadin

Liechtenstein

31.8.2008

EU/1/07/394/007-009

Optaflu

Liechtenstein

31.8.2008

EU/1/07/400/017/NO-021/NO

Mircera

Norway

13.10.2008

EU/1/07/400/017-020/IS

Mircera

Iceland

17.10.2008

EU/1/07/400/017-021

Mircera

Liechtenstein

31.10.2008

EU/1/07/410/017-020

Binocrit

Liechtenstein

31.8.2008

EU/1/07/411/017-020

Epoetin alfa Hexal

Liechtenstein

31.8.2008

EU/1/07/412/017-020

Abseamed

Liechtenstein

31.8.2008

EU/1/07/414/018

Galvus

Liechtenstein

31.10.2008

EU/1/07/419/010-012

Cervarix

Liechtenstein

31.12.2008

EU/1/07/431/020/NO-025/NO

Retacrit

Norway

15.12.2008

EU/1/07/431/020-025

Retacrit

Liechtenstein

31.12.2008

EU/1/07/432/020-022

Silapo

Liechtenstein

31.8.2008

EU/1/95/003/007/NO-008/NO

Betaferon

Norway

13.11.2008

EU/1/95/003/007-008

Betaferon

Liechtenstein

31.12.2008

EU/1/97/030/140/NO-169/NO

Insuman

Norway

1.12.2008

EU/1/97/030/140-169

Insuman

Liechtenstein

31.12.2008

EU/102/206/021/NO-035/NO

Arixtra

Norway

8.9.2008

EU/102/206/021-035

Arixtra

Liechtenstein

31.10.2008

EU/2/02/033/002

Dexdomitor

Liechtenstein

31.8.2008

EU/2/05/054/018/NO-031/NO

Profender

Norway

24.9.2008

EU/2/05/054/018-031

Profender

Liechtenstein

31.10.2008

EU/2/05/054/018-031/IS

Profender

Iceland

1.10.2008

EU/2/06/058/004

Flexicam

Liechtenstein

31.12.2008

EU/2/99/015/002

Oxyglobin

Liechtenstein

31.10.2008

---

ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of withdrawal |
| --- | --- | --- | --- |
| EU/1/01/184/001-073 | Nespo | Liechtenstein | 31.12.2008 |
| EU/1/01/185/023-030 | Aranesp | Liechtenstein | 31.12.2008 |
| EU/1/02/202/001-006 | Protopy | Liechtenstein | 31.10.2008 |
| EU/1/02/202/001-006/IS | Protopy | Iceland | 27.9.2008 |
| EU/1/02/228/001-003 | Neupopeg | Liechtenstein | 31.12.2008 |
| EU/1/04/293/001-012 | Parareg | Liechtenstein | 31.12.2008 |
| EU/1/04/301/001/NO-005/NO | Quintanrix | Norway | 25.11.2008 |
| EU/1/04/301/001-005 | Quintanrix | Liechtenstein | 31.10.2008 |
| EU/1/04/301/001-005/IS | Quintanrix | Iceland | 27.9.2008 |
| EU/1/05/327/001/NO-018/NO | Exubera | Norway | 25.11.2008 |
| EU/1/05/327/001-018 | Exubera | Liechtenstein | 31.10.2008 |
| EU/1/05/327/001-018/IS | Exubera | Iceland | 22.10.2008 |
| EU/1/98/093/002 | Forcaltonin | Liechtenstein | 31.12.2008 |
| EU/1/98/093/002/IS | Forcaltonin | Iceland | 29.11.2008 |
| EU/1/98/093/002/NO | Forcaltonin | Norway | 25.11.2008 |
| EU/1/99/128/001/NO-037/NO | Viraferon | Norway | 29.10.2008 |
| EU/1/99/128/001-037 | Viraferon | Liechtenstein | 31.10.2008 |
| EU/1/99/128/001-037/IS | Viraferon | Iceland | 22.10.2008 |

EU-Number

Product

Country

Date of withdrawal

EU/1/01/184/001-073

Nespo

Liechtenstein

31.12.2008

EU/1/01/185/023-030

Aranesp

Liechtenstein

31.12.2008

EU/1/02/202/001-006

Protopy

Liechtenstein

31.10.2008

EU/1/02/202/001-006/IS

Protopy

Iceland

27.9.2008

EU/1/02/228/001-003

Neupopeg

Liechtenstein

31.12.2008

EU/1/04/293/001-012

Parareg

Liechtenstein

31.12.2008

EU/1/04/301/001/NO-005/NO

Quintanrix

Norway

25.11.2008

EU/1/04/301/001-005

Quintanrix

Liechtenstein

31.10.2008

EU/1/04/301/001-005/IS

Quintanrix

Iceland

27.9.2008

EU/1/05/327/001/NO-018/NO

Exubera

Norway

25.11.2008

EU/1/05/327/001-018

Exubera

Liechtenstein

31.10.2008

EU/1/05/327/001-018/IS

Exubera

Iceland

22.10.2008

EU/1/98/093/002

Forcaltonin

Liechtenstein

31.12.2008

EU/1/98/093/002/IS

Forcaltonin

Iceland

29.11.2008

EU/1/98/093/002/NO

Forcaltonin

Norway

25.11.2008

EU/1/99/128/001/NO-037/NO

Viraferon

Norway

29.10.2008

EU/1/99/128/001-037

Viraferon

Liechtenstein

31.10.2008

EU/1/99/128/001-037/IS

Viraferon

Iceland

22.10.2008

---

ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2008:

| EU-Number | Product | Country | Date of suspension |
| --- | --- | --- | --- |
| EU/1/06/344/001-011 | Acomplia | Liechtenstein | 31.12.2008 |
| EU/1/06/344/001-011/IS | Acomplia | Iceland | 26.11.2008 |
| EU/1/06/345/001-011 | Zimulti | Liechtenstein | 31.12.2008 |
| EU/1/06/345/001-011/IS | Zimulti | Iceland | 26.11.2008 |

EU-Number

Product

Country

Date of suspension

EU/1/06/344/001-011

Acomplia

Liechtenstein

31.12.2008

EU/1/06/344/001-011/IS

Acomplia

Iceland

26.11.2008

EU/1/06/345/001-011

Zimulti

Liechtenstein

31.12.2008

EU/1/06/345/001-011/IS

Zimulti

Iceland

26.11.2008

---

V Announcements

OTHER ACTS

Commission

| 24.9.2009 | EN | Official Journal of the European Union | C 230/29 |
| --- | --- | --- | --- |

24.9.2009

EN

Official Journal of the European Union

C 230/29

---

Notice for the attention of Ghuma Abd’rabbah concerning his inclusion in the list referred to in Articles 2, 3 and 7 of Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with Usama bin Laden, the Al-Qaida network and the Taliban

2009/C 230/09

| 1. | Common Position 2002/402/CFSP (1) calls upon the Community to freeze the funds and economic resources of Usama bin Laden, members of the Al-Qaida organisation and the Taliban and other individuals, groups, undertakings and entities associated with them, as referred to in the list drawn up pursuant to UNSCR 1267(1999) and 1333(2000) to be updated regularly by the UN Committee established pursuant to UNSCR 1267(1999).
  The list drawn up by this UN Committee comprises:






  — | Al-Qaida, the Taliban and Mr Usama bin Laden, |
| --- | --- | --- |

1.

Common Position 2002/402/CFSP (1) calls upon the Community to freeze the funds and economic resources of Usama bin Laden, members of the Al-Qaida organisation and the Taliban and other individuals, groups, undertakings and entities associated with them, as referred to in the list drawn up pursuant to UNSCR 1267(1999) and 1333(2000) to be updated regularly by the UN Committee established pursuant to UNSCR 1267(1999).

The list drawn up by this UN Committee comprises:

—

Al-Qaida, the Taliban and Mr Usama bin Laden,

| — | natural or legal persons, entities, bodies and groups associated with Al-Qaida, the Taliban and Mr Usama bin Laden, and |
| --- | --- |

—

natural or legal persons, entities, bodies and groups associated with Al-Qaida, the Taliban and Mr Usama bin Laden, and

| — | legal persons, entities and bodies owned or controlled by, or otherwise supporting, any of these associated persons, entities, bodies and groups. |
| --- | --- |

—

legal persons, entities and bodies owned or controlled by, or otherwise supporting, any of these associated persons, entities, bodies and groups.

Acts or activities indicating that an individual, group, undertaking, or entity is ‘associated with’ Al-Qaida, Usama bin Laden or the Taliban include:

| (a) | participating in the financing, planning, facilitating, preparing, or perpetrating of acts or activities by, in conjunction with, under the name of, on behalf of, or in support of, Al-Qaida, the Taliban or Mr Usama bin Laden, or any cell, affiliate, splinter group or derivative thereof; |
| --- | --- |

(a)

participating in the financing, planning, facilitating, preparing, or perpetrating of acts or activities by, in conjunction with, under the name of, on behalf of, or in support of, Al-Qaida, the Taliban or Mr Usama bin Laden, or any cell, affiliate, splinter group or derivative thereof;

| (b) | supplying, selling or transferring arms and related materiel to any of them; |
| --- | --- |

(b)

supplying, selling or transferring arms and related materiel to any of them;

| (c) | recruiting for any of them; or |
| --- | --- |

(c)

recruiting for any of them; or

| (d) | otherwise supporting acts or activities of any of them. |
| --- | --- |

(d)

otherwise supporting acts or activities of any of them.

| 2. | The UN Committee decided on 7 February 2006 to add Mr Ghuma Abd’rabbah to the relevant list.
  The natural person concerned may submit at any time a request to the UN Committee, together with any supporting documentation, for the decision to include him in the UN list referred to above, to be reconsidered. Such request should be sent to the following address:





  United Nations — Focal point for delisting |
| --- | --- |
| Security Council Subsidiary Organs Branch |
| Room S-3055 E |
| New York, NY 10017 |
| UNITED STATES OF AMERICA |

2.

The UN Committee decided on 7 February 2006 to add Mr Ghuma Abd’rabbah to the relevant list.

The natural person concerned may submit at any time a request to the UN Committee, together with any supporting documentation, for the decision to include him in the UN list referred to above, to be reconsidered. Such request should be sent to the following address:

United Nations — Focal point for delisting

Security Council Subsidiary Organs Branch

Room S-3055 E

New York, NY 10017

UNITED STATES OF AMERICA

See for more information at: http://www.un.org/sc/committees/1267/delisting.shtml

| 3. | Further to this decision the Commission (2) has included Mr Ghuma Abd’rabbah in Annex I to Council Regulation (EC) No 881/2002 (3) imposing certain specific restrictive measures directed against certain persons and entities associated with Usama bin Laden, the Al-Qaida network and the Taliban.
  The following measures of Regulation (EC) No 881/2002 apply to the natural and legal persons, groups and entities concerned:






  (a) | the freezing of all funds, other financial assets and economic resources belonging to them, or owned or held by them, and the prohibition to make funds, other financial assets and economic resources available to them or for their benefit, whether directly or indirectly (Articles 2 and 2a) (4)); and |
| --- | --- | --- |

3.

Further to this decision the Commission (2) has included Mr Ghuma Abd’rabbah in Annex I to Council Regulation (EC) No 881/2002 (3) imposing certain specific restrictive measures directed against certain persons and entities associated with Usama bin Laden, the Al-Qaida network and the Taliban.

The following measures of Regulation (EC) No 881/2002 apply to the natural and legal persons, groups and entities concerned:

(a)

the freezing of all funds, other financial assets and economic resources belonging to them, or owned or held by them, and the prohibition to make funds, other financial assets and economic resources available to them or for their benefit, whether directly or indirectly (Articles 2 and 2a) (4)); and

| (b) | the prohibition to grant, sell, supply or transfer technical advice, assistance or training related to military activities to them, whether directly or indirectly (Article 3). |
| --- | --- |

(b)

the prohibition to grant, sell, supply or transfer technical advice, assistance or training related to military activities to them, whether directly or indirectly (Article 3).

| 4. | Following the judgement of the Court of Justice of 3 September 2008 in Joined Cases C-402/05 P and C-415/05 P, Yassin Abdullah Kadi and Al Barakaat International Foundation v. Council, the UN Committee has provided grounds for listing of Mr Ghuma Abd’rabbah.
  He may make a request for the grounds for his listing to the Commission. This request should be sent to:





  European Commission |
| --- | --- |
| ‘Restrictive measures’ |
| Rue de la Loi/Wetstraat 200 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

Following the judgement of the Court of Justice of 3 September 2008 in Joined Cases C-402/05 P and C-415/05 P, Yassin Abdullah Kadi and Al Barakaat International Foundation v. Council, the UN Committee has provided grounds for listing of Mr Ghuma Abd’rabbah.

He may make a request for the grounds for his listing to the Commission. This request should be sent to:

European Commission

‘Restrictive measures’

Rue de la Loi/Wetstraat 200

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

After having given him an opportunity to express his views on the grounds for listing, the Commission will review his inclusion in Annex I to Council Regulation (EC) No 881/2002 and a new decision concerning him will be made.

| 5. | Personal data provided by Mr Ghuma Abd’rabbah will be handled in accordance with the rules of Regulation (EC) No 45/2001 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data (5). Any request, e.g. for further information or in order to exercise the rights under Regulation (EC) No 45/2001 (e.g. access or rectification of personal data), should be sent to the Commission at the address mentioned under point 4 above. |
| --- | --- |

5.

Personal data provided by Mr Ghuma Abd’rabbah will be handled in accordance with the rules of Regulation (EC) No 45/2001 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data (5). Any request, e.g. for further information or in order to exercise the rights under Regulation (EC) No 45/2001 (e.g. access or rectification of personal data), should be sent to the Commission at the address mentioned under point 4 above.

| 6. | For good order, the attention of the natural persons listed in Annex I is drawn to the possibility of making an application to the competent authorities of the relevant Member State(s), as listed in Annex II to Regulation (EC) No 881/2002, in order to obtain an authorisation to use frozen funds, other financial assets and economic resources for essential needs or specific payments in accordance with Article 2a) of that Regulation. |
| --- | --- |

6.

For good order, the attention of the natural persons listed in Annex I is drawn to the possibility of making an application to the competent authorities of the relevant Member State(s), as listed in Annex II to Regulation (EC) No 881/2002, in order to obtain an authorisation to use frozen funds, other financial assets and economic resources for essential needs or specific payments in accordance with Article 2a) of that Regulation.

---

(1)  OJ L 139, 29.5.2002, p. 4. Common Position as last amended by Common Position 2003/140/CFSP (OJ L 53, 28.2.2003, p. 62).

(2)  Regulation (EC) No 246/2006 (OJ L 40, 11.2.2006, p. 13).

(3)  OJ L 139, 29.5.2002, p. 9.

(4)  Article 2a) was inserted by Council Regulation (EC) No 561/2003 (OJ L 82, 29.3.2003, p. 1).

(5)  OJ L 8, of 12.1.2001, p. 1.

---